| |
original article |
Journal |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
Future Microbiology |
2024―May―31 |
Severe mold fungal infections in critically ill patients with COVID-19 |
Despoina Koulenti, Elisabeth Paramythiotou, Maria Panagiota Almyroudi, Marios Karvouniaris, Nikolaos Markou, Paschalis Paranos, Christina Routsi, Joseph Meletiadis, Stijn Blot |
| 2 |
[GO] |
Future Microbiology |
2024―May―23 |
Online dashboards for SARS-CoV-2 wastewater-based epidemiology |
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi |
| 3 |
[GO] |
Biomarkers in Medicine |
2024―May―17 |
Pre-Analytical Sample Handling Effects on Blood Cytokine Levels: Quality Control of A Covid-19 Biobank |
Inge MW Verberk, Esther J Nossent, Hetty J Bontkes, Charlotte E Teunissen |
| 4 |
[GO] |
Future Oncology |
2024―Apr―29 |
Impact of COVID-19 on patients with metastatic breast cancer: REthink Access to Care and Treatment survey results |
Neil M Iyengar, Clay Williams, Michael Rogan, Laurie Campbel, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K Kurosky, Timothy J Pluard |
| 5 |
[GO] |
Future Microbiology |
2024―Apr―17 |
JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants |
Soumya Basu, Titirsha Kayal, Ponoop Prasad Patro, Amit Patnaik |
| 6 |
[GO] |
Future Virology |
2024―Apr―12 |
RNAi-mediated inhibition of SARS-CoV-2: applications and challenges |
Debosmita Sanyal, Binay Chaubey |
| 7 |
[GO] |
Future Virology |
2024―Mar―26 |
Exploration of the cross-immunity between SARS-CoV and SARS-CoV-2 in mice |
Shuhui Wang, Li Ren, Ying Liu, Xiuli Shen, Yanling Hao, Yiming Shao |
| 8 |
[GO] |
Future Virology |
2024―Mar―18 |
Direct virus capture assay for label-free detection of SARS-CoV-2 virions using laser microscopy |
Alessandro Pennesi, Guglielmo Ferrari, Federica Giardina, Sara Piselli, Roberto Lo Savio, Adolfo Carloni, Stefania Paolucci, Fausto Baldanti |
| 9 |
[GO] |
Future Virology |
2024―Feb―26 |
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir |
Roberta Monardo, Andrea Mastrangelo, Laura Galli, Alessandro Tomelleri, Vincenzo Spagnuolo, Chiara Oltolini, Giacomo Ponta, Corrado Campochiaro, Giulio Cavalli, Lorenzo Dagna, Fabio Ciceri, Paola Cinque, Paolo Scarpellini, Antonella Castagna, Marco Ripa |
| 10 |
[GO] |
Pain Management |
2024―Feb―20 |
Prevalence of abnormal urine drug tests during COVID-19 pandemic in the cancer patient population: retrospective study |
Vishal Bansal, Loc Lam, Ashlyn Victoria Brown, Saba Javed |
| 11 |
[GO] |
Future Virology |
2024―Feb―09 |
Developing a risk prediction model for COVID-19 infection in heart transplant recipients using artificial intelligence |
Shriya Sharma, Nora Menon, Jose Ruiz, Caitlyn Luce, Lisa Brumble, Anirban Bhattacharya, Rohan Goswami |
| 12 |
[GO] |
Future Virology |
2024―Feb―05 |
Preliminary application of a coronavirus pseudovirus system |
Xiaoli Tao, Tengfei Li, Baojun He, Wei Zhao, Siman Hu, Zhuping Ma, Lvyin Sun, Runlin Li, Like Luo, Yonggang Li |
| 13 |
[GO] |
Future Microbiology |
2024―Jan―31 |
Development of a machine learning model to predict risk of development of COVID-19-associated mucormycosis |
Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza |
| 14 |
[GO] |
Future Microbiology |
2024―Jan―31 |
Triple in silico targeting of IMPDH enzyme and RNA-dependent RNA polymerase of both SARS-CoV-2 and Rhizopus oryzae |
Abdel-moniem S Hassan, Abdo A Elfiky, Alaa M Elgohary |
| 15 |
[GO] |
Biomarkers in Medicine |
2024―Jan―15 |
Blood biomarkers: a new solution to the silent pandemic of traumatic brain injury |
Charalampos Tsakiris, Timoleon Siempis, Georgios D Lianos, Labrini Vlachodimitropoulou, Spyridon Voulgaris, George A Alexiou |
| 16 |
[GO] |
Future Virology |
2023―Dec―21 |
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study |
Sambhavi Subramanian, Gretja Schnell, Julia di Iulio, Anil K Gupta, Adrienne E Shapiro, Elias H Sarkis, Amanda Lopuski, Amanda Peppercorn, Melissa Aldinger, Christy M Hebner, Andrea L Cathcart |
| 17 |
[GO] |
Future Virology |
2023―Dec―19 |
Effect of the COVID-19 pandemic on the reporting of Crimean-Congo hemorrhagic fever |
Mohammad Hassan Pouriayevali, Ehsan Mostafavi, Mehdi Fazlalipour, Tahmineh Jalali, Sahar Khakifirouz, Seyed Dawood Mosavi-Nasab, Mostafa Salehi-Vaziri |
| 18 |
[GO] |
Future Virology |
2023―Nov―07 |
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study |
Shahd A Mohammedain, Saif Badran, AbdelNaser Y Elzouki, Halla Salim, Ayesha Chalaby, MYA Siddiqui, Yehia Y Hussein, Hanan Abdul Rahim, Lukman Thalib, Mohammed Fasihul Alam, Daoud Al-Badriyeh, Sumaya Al-Maadeed, Suhail AR Doi |
| 19 |
[GO] |
Future Virology |
2023―Nov―07 |
Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection |
Soumik Goswami, Jayita Pal Chowdhury |
| 20 |
[GO] |
Future Virology |
2023―Nov―01 |
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY) |
Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, Abraham Simón-Campos, Keith Pietropaolo, William J Stubbings, Neil Collinson, Laura Ishak, Barbara Zrinscak, Bruce Belanger, Catherine Granier, Kai Lin, Aeron C Hurt, Xiao-Jian Zhou, Steffen Wildum, Janet Hammond |
| 21 |
[GO] |
Future Microbiology |
2023―Nov―01 |
Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients |
Murat Karamese, Abdullah Gumus, Eray Atalay, Emin E Tutuncu |
| 22 |
[GO] |
Future Virology |
2023―Oct―26 |
In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes |
Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari |
| 23 |
[GO] |
Future Microbiology |
2023―Oct―20 |
Plain language summary: Did the COVID-19 pandemic change the resistance to current antifungal medicines? |
Michael A Pfaller, Cecilia G Carvalhaes, Sean DeVries, Paul R Rhomberg, Mariana Castanheira |
| 24 |
[GO] |
Future Microbiology |
2023―Oct―18 |
Characteristics of COVID-19 and mortality-associated factors during the first year of the pandemic in southeast Mexico |
Jorge A Rangel-Méndez, Luciola Jaimes-Gurrusquieta, Juan F Sánchez-Cruz, Ma I Zarate-Murillo, Jessica Domínguez-Méndez, Hugo A Laviada-Molina, Daniel Casares-González, Elideth M Flores-Flores |
| 25 |
[GO] |
Future Virology |
2023―Oct―18 |
Genotoxicity: a neglected but potentially critical aspect of adenoviral COVID-19 vaccines |
Alireza Mardomi, Tahoora Mousavi, Farahnoosh Farnood, Hamid Tayebi Khosroshahi |
| 26 |
[GO] |
Future Microbiology |
2023―Sep―26 |
Has coronavirus disease 2019 changed clinical microbiology laboratories forever? |
Joseph M Blondeau, Jennifer Coetzee |
| 27 |
[GO] |
Future Virology |
2023―Sep―19 |
‘The end’ - or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants |
Farid Rahimi, Mohammad Darvishi, Amin Talebi Bezmin Abadi |
| 28 |
[GO] |
Nanomedicine |
2023―Sep―15 |
Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine |
Bruna Rodrigues Dias Assis, Isabela Pereira Gomes, Júlia Teixeira de Castro, Graziella Gomes Rivelli, Natália Salazar de Castro, Diana Paola Gomez-Mendoza, Flávia Fonseca Bagno, Natália Satchiko Hojo-Souza, Ana Luiza Chaves Maia, Eduardo Burgarelli Lages, Flávio Guimaraes da Fonseca, Santuza Maria Ribeiro Teixeira, Ana Paula Fernandes, Ricardo Tostes Gazzinelli, Gisele Assis Castro Goulart |
| 29 |
[GO] |
Future Virology |
2023―Sep―11 |
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy |
Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari |
| 30 |
[GO] |
Future Microbiology |
2023―Sep―05 |
Pandemic predictions and precautionary preparations: lessons from history |
Thomas H Pennington |
| 31 |
[GO] |
Epigenomics |
2023―Sep―04 |
Clinically informative microRNAs for SARS-CoV-2 infection |
Sercan Ergün, Ramamoorthy Sankaranarayanan, Nina Petrović |
| 32 |
[GO] |
Biomarkers in Medicine |
2023―Aug―31 |
Differential absolute plasma IL-6 concentrations between two immunoassay platforms in intensive care unit patients with COVID-19 |
Pavan K Bhatraju, Eric D Morrell, Nicholas G O'Connor, Audrey Choi, Michael Fitzpatrick, Craig H Smith, Mark M Wurfel, Wayne Conrad Liles |
| 33 |
[GO] |
Regenerative Medicine |
2023―Aug―17 |
Comment on ‘Digital transformation of medical education: innovative pedagogy and regenerative surgery in the era of COVID-19’ |
Evelyn Casilla-Huamán |
| 34 |
[GO] |
Regenerative Medicine |
2023―Aug―09 |
Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19 |
Gaurav Gupta, Md Sadique Hussain, Riya Thapa, Rajiv Dahiya, Debarshi Kar Mahapatra, Asif Ahmad Bhat, Neelam Singla, Vetriselvan Subramaniyan, Sushama Rawat, Vikas Jakhmola, Roshan S, Kamal Dua |
| 35 |
[GO] |
Future Virology |
2023―Jul―28 |
Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age |
CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, D Finkelstein, P Pickrell, J Kirstein, C Yut, R Blair, RA Clifford, M Dunn, JD Campbell, DC Montefiori, JE Tomassini, X Zhao, W Deng, H Zhou, D Ramirez Schrempp, K Hautzinger, B Girard, K Slobod, R McPhee, R Pajon, R Das, JM Miller, S Schnyder Ghamloush |
| 36 |
[GO] |
Future Microbiology |
2023―Jul―14 |
Antibiotic dispensing during first year of COVID-19 pandemic in Brazilian public hospitals |
Maria LS Pereira, Davi AC Mothé, Kézia S Pinheiro, Sarah S Gonçalves, Kênia V Santos |
| 37 |
[GO] |
Future Virology |
2023―Jul―13 |
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 |
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh |
| 38 |
[GO] |
Immunotherapy |
2023―Jul―11 |
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic |
Gordon Taylor Moffat, Lilian Hanna, Wilma Hopman, Andrea S Fung, Pierre-Olivier Gaudreau |
| 39 |
[GO] |
Future Virology |
2023―Jun―24 |
Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation |
Cao Minh Nguyen, Bac An Luong, Thu Thuy Thi Tran, Hoai Nghia Nguyen, Le Son Tran |
| 40 |
[GO] |
Future Virology |
2023―Jun―23 |
Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 |
Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, Keith Pietropaolo, Bruce Belanger, Kai Lin, Kristen Perkins, Janet Hammond |
| 41 |
[GO] |
Future Cardiology |
2023―Jun―22 |
A young woman with pulmonary embolism, myocarditis and fungal endocarditis after COVID-19 infection: a case report |
Mehran Lak, Sepideh Jafari Naeini, Alireza Omidi Farzin, Manoochehr Hekmat, Atoosa Gharib |
| 42 |
[GO] |
Biomarkers in Medicine |
2023―Jun―20 |
Association between the copper/selenium ratio and the immune response to SARS-CoV-2 infection |
Mahnaz Tashakori, Ahmad Jamalizadeh, Mohsen Nejad-Ghaderi, Maryam Hadavi, Aliakbar Yousefi-Ahmadipour, Fatemeh M Moghadam, Maryam Rahnama, Saeed M Haftcheshmeh, Kazem Mashayekhi, Amir A Momtazi-Borojeni |
| 43 |
[GO] |
Future Virology |
2023―Jun―16 |
COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities |
Abdul Mannan Baig, Joachim Gerlach, Prakash Salunke, Rachel Jessey, Robin Rose |
| 44 |
[GO] |
Future Virology |
2023―Jun―16 |
Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity |
Joachim Gerlach, Abdul Mannan Baig |
| 45 |
[GO] |
Future Virology |
2023―Jun―07 |
Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach |
Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza, Hermógenes D de Oliveira |
| 46 |
[GO] |
Future Virology |
2023―Jun―01 |
CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice |
Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, Meirong Wang, Yan Chen, Yan Shao, Jiankai Liu |
| 47 |
[GO] |
Future Virology |
2023―Jun―01 |
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins |
Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari |
| 48 |
[GO] |
Future Virology |
2023―May―22 |
In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease |
Yousef A Abdelrady, Naeem Mahmood Ashraf, Arslan Hamid, Hayam S Thabet, Asmaa M Sayed, Shimaa H Salem, Emad HM Hassanein, Ahmed M Sayed |
| 49 |
[GO] |
Future Virology |
2023―May―22 |
Identification of host factors that bind to the 5′ end of the MERS-CoV RNA genome |
Bader Y Alhatlani, Waleed Aljabr, Fatimah S Alhamlan, Ahmad Almatroudi, Mohd Azam, Mansour Alsaleem, Khaled S Allemailem |
| 50 |
[GO] |
Epigenomics |
2023―May―02 |
COVID-19 and cancer: insights into their association and influence on genetic and epigenetic landscape |
Mrinal K Ghosh, Sunny Kumar, Kirat K Ganguly, Pratyay Ghosh, Shaheda Tabassum, Bhaskar Basu, Malini Basu |
| 51 |
[GO] |
Future Virology |
2023―Apr―17 |
Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit |
Francesco Chirico, Murat Yıldırım, Tomasz Dzieciatkowski, Marek Dabrowski, Marek Malysz, Marcin Madziala, Milosz Jaroslaw Jaguszewski, Karol Bielski, Gabriella Nucera, Krzysztof J Filipiak, Lukasz Szarpak |
| 52 |
[GO] |
Future Virology |
2023―Apr―11 |
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes |
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu |
| 53 |
[GO] |
Biomarkers in Medicine |
2023―Apr―11 |
Comparison of thromboembolic risk scores for evaluating in-hospital events of COVID-19 patients |
Ömer Genç, Abdullah Yildirim, Mürşide Genç, Fahri Er, Gökhan Alici, Alaa Quisi, Hazar Harbalioğlu, Samir Allahverdiyev, İbrahim H Kurt |
| 54 |
[GO] |
Future Virology |
2023―Apr―11 |
In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover |
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Dyane Rocha Aragão, Expedito Maia Diógenes, Emerson Lucena da Silva, Jackson Lima Amaral, Valder Nogueira Freire, Débora de Souza Collares Maia Castelo-Branco, Raquel Carvalho Montenegro |
| 55 |
[GO] |
Future Virology |
2023―Apr―06 |
The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex |
Mykyta Peka, Viktor Balatsky |
| 56 |
[GO] |
Future Virology |
2023―Apr―04 |
Evidence-based policies in public health to address COVID-19 vaccine hesitancy |
Francesco Chirico, Jaime A Teixeira da Silva |
| 57 |
[GO] |
Personalized Medicine |
2023―Mar―28 |
SARS-CoV-2 variant identification using a genome tiling array and genotyping probes |
Ryota Shimada, Emily N Alden, Kendall Hoff, Xun Ding, Jiayi Sun, Adam M Halasz, Wei Zhou, Jeremy S Edwards |
| 58 |
[GO] |
Future Microbiology |
2023―Mar―14 |
Long-term effects of COVID-19 on lungs and the clinical relevance: a 6-month prospective cohort study |
Gulsah Tuncer, Ceyda Geyiktepe-Guclu, Serkan Surme, Evren Canel-Karakus, Hatice Erdogan, Osman F Bayramlar, Cansu Belge, Ridvan Karahasanoglu, Betul Copur, Meltem Yazla, Esra Zerdali, Inci Y Nakir, Nihal Yildirim, Bedriye Kar, Mediha Bozkurt, Kubra Karanalbant, Burcu Atasoy, Hindirin Takak, Serap Simsek-Yavuz, Rustu Turkay, Mehmet M Sonmez, Gonul Sengoz, Filiz Pehlivanoglu |
| 59 |
[GO] |
Future Virology |
2023―Mar―14 |
Natural killer cells in COVID-19: from infection, to vaccination and therapy |
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi |
| 60 |
[GO] |
Future Virology |
2023―Mar―09 |
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? |
Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed-Hamidreza Mozhgani |
| 61 |
[GO] |
Future Virology |
2023―Mar―06 |
Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike |
Massimo Ciccozzi, Stefano Pascarella |
| 62 |
[GO] |
Future Virology |
2023―Feb―20 |
HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors |
William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, Lucie Richard, Antoine Lewin, Patrick Trépanier |
| 63 |
[GO] |
Concussion |
2023―Feb―13 |
Return-to-learn after concussion in Washington state public high schools during the COVID-19 pandemic |
Shyam J Deshpande, Aspen Avery, Julian Takagi-Stewart, Brianna Mills, Qian Qiu, Monica S Vavilala |
| 64 |
[GO] |
Future Virology |
2023―Feb―03 |
SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening |
Jiahui Wu, Zhiqiang Chen, Xue Han, Qiaoqiao Chen, Yintao Wang, Tingting Feng |
| 65 |
[GO] |
Future Virology |
2023―Jan―27 |
Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern? |
Chandan Kumar Thakur, Jog Bahadur Adhikari, Nitin Gupta, Prakash Ghimire, Meghnath Dhimal |
| 66 |
[GO] |
Future Virology |
2023―Jan―19 |
Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19 |
Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge, Jun Ning |
| 67 |
[GO] |
Future Microbiology |
2023―Jan―17 |
Mucormycosis in the COVID-19 scenario beyond hospitalized patients |
Alexandro Bonifaz, Andrés Tirado-Sánchez, Javier Araiza, María Luisa Hernández-Medel |
| 68 |
[GO] |
Future Virology |
2023―Jan―16 |
Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old |
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L Perez, Emmanuel B Walter, Shelly Senders, Ruth Bailey, Kena A Swanson, Hua Ma, Xia Xu, Kenneth Koury, Warren V Kalina, David Cooper, Timothy Jennings, Donald M Brandon, Stephen J Thomas, Özlem Türeci, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, Kathrin U Jansen, William C Gruber |
| 69 |
[GO] |
Immunotherapy |
2023―Jan―11 |
Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients |
Mehrsa Jalalizadeh, Cristiane F Giacomelli, Patricia AF Leme, Keini Buosi, Luciana SB Dal Col, Franciele AV Dionato, Cristiane L Maia, Reza Yadollahvandmiandoab, Adilson P Domingues-Junior, Leonardo O Reis |
| 70 |
[GO] |
Future Virology |
2023―Jan―10 |
Diagnosing COVID-19: diagnostic importance of detecting E gene of the SARS-CoV-2 genome |
Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa |
| 71 |
[GO] |
Future Virology |
2023―Jan―09 |
The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran |
Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Elahe Ghorbani Totkaboni, Haniyeh Sadat Fayazi |
| 72 |
[GO] |
Pain Management |
2022―Dec―14 |
Pain management recommendations during the progression of SARS-CoV-2 infection |
Arti Dhar, Preeti Kachroo, Maxime Herve, Richard Petruschke |
| 73 |
[GO] |
Regenerative Medicine |
2022―Dec―01 |
A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products |
Enric Redondo Monte, David O'Neill, Karin M Abitorabi |
| 74 |
[GO] |
Future Virology |
2022―Nov―25 |
Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older |
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini, Ruth Bailey, Kena A Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V Kalina, David Cooper, Robert W Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, William C Gruber, Kathrin U Jansen |
| 75 |
[GO] |
Future Oncology |
2022―Nov―11 |
The impact of telemedicine on cancer care: real-world experience from a Peruvian institute during the COVID-19 pandemic |
Katia Roque, Rossana Ruiz, Iris Otoya-Fernandez, José Galarreta, Tatiana Vidaurre, Ramon Andrade de Mello, Silvia Neciosup, Luis Mas, Henry Gómez |
| 76 |
[GO] |
Future Cardiology |
2022―Nov―02 |
2D speckle-tracking echocardiography as a prognostic imaging modality for COVID-19 adverse outcomes |
Ehsan Goudarzi, Fateme Yousefimoghaddam, Alireza Ramandi, Isa Khaheshi |
| 77 |
[GO] |
Neurodegenerative Disease Management |
2022―Oct―24 |
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary |
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
| 78 |
[GO] |
Future Virology |
2022―Oct―22 |
Variation analysis of SARS-CoV-2 complete sequences from Iran |
Jale Moradi, Parnia Moradi, Amir H Alvandi, Ramin Abiri, Mohsen Moghoofei |
| 79 |
[GO] |
Future Oncology |
2022―Oct―17 |
Remote consultations: experiences of UK patients with prostate cancer during the COVID-19 pandemic |
Rebecca Leszczynski, Natalia Norori, Steve Allen, Raj Persad, Toby Page, William Cross, Emma Craske, Henry Lovett, Karen Stalbow |
| 80 |
[GO] |
Future Virology |
2022―Oct―17 |
Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers |
Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Melike Nur Ozcelik, Hulya Yilmaz-Ak, Muge Topal, Sumeyye Ustun-Al, Filiz Pehlivanoglu, Gonul Sengoz |
| 81 |
[GO] |
Future Microbiology |
2022―Oct―06 |
Acinetobacter baumannii infections resistant to treatment: warning signs from the COVID-19 pandemic |
Ryan C Ellis, Elena K Roberts, Jennifer T Grier, Steven E Fiester |
| 82 |
[GO] |
Future Oncology |
2022―Sep―29 |
Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre |
Maria J Monroy-Iglesias, Kathryn Tremble, Beth Russell, Charlotte Moss, Saoirse Dolly, Ailsa Sita-Lumsden, Alessio Cortellini, David James Pinato, Anne Rigg, Sophia N Karagiannis, Mieke Van Hemelrijck |
| 83 |
[GO] |
Future Microbiology |
2022―Sep―28 |
Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data |
Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Filiz Pehlivanoglu, Gonul Sengoz |
| 84 |
[GO] |
Future Virology |
2022―Sep―26 |
Reinfection and reactivation of SARS-CoV-2 |
Razieh Dowran, Amirmasoud Rayati Damavandi, Talat Mokhtari Azad |
| 85 |
[GO] |
Future Virology |
2022―Sep―26 |
Rapid antigen test for SARS-CoV-2: results of validation and use in real life |
Irena Grmek Kosnik, Urska Dermota, Andrej Golle, Tjasa Zohar Cretnik |
| 86 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―Sep―23 |
Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control design |
Matthew W Reynolds, Alex Secora, Alice Joules, Lisa Albert, Emma Brinkley, Tom Kwon, Christina Mack, Stephen Toovey, Nancy A Dreyer |
| 87 |
[GO] |
Future Virology |
2022―Sep―23 |
Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations |
Ömer Kutlu, Selami Aykut Temiz |
| 88 |
[GO] |
Future Virology |
2022―Sep―16 |
Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support? |
Patrice Dufour, Henry Paridaens, Jean-Marc Senterre, Jean-Marc Minon |
| 89 |
[GO] |
Future Microbiology |
2022―Sep―16 |
Elevated IL-18 predicts poor prognosis in critically ill COVID-19 patients at a Brazilian hospital in 2020-21 |
Lucyana LC Coutinho, Caroline N Oliveira, Polianna LMM Albuquerque, Sandra MB Mota, Gdayllon C Meneses, Alice MC Martins, Geraldo BS Junior, Marco AF Clementino, Rafhaella NDG Gondim, Alexandre Havt, Luciano PG Cavalcanti, Juliana NU Yaochite |
| 90 |
[GO] |
Future Microbiology |
2022―Sep―16 |
Comment on: ‘Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients’ |
Esmeralda Garza-Santiago, Alejandro Ortiz-Hernández, Ashuin Kammar-García, Javier Mancilla-Galindo |
| 91 |
[GO] |
Future Virology |
2022―Sep―14 |
A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster |
Frank Struyf, Jerald Sadoff, Karin Hardt, Macaya Douoguih |
| 92 |
[GO] |
Biomarkers in Medicine |
2022―Sep―13 |
Role of plasma angiotensin II and angiotensin-converting enzyme 2 levels on prognosis and mortality in hypertensive patients with COVID-19 |
Serap Biberoğlu, Afşin İpekci, İbrahim İkizceli, Fatih Çakmak, Yonca S Akdeniz, Altuğ Kanbakan, Dildar Konukoğlu, İbrahim M Bolayırlı, Şermin Börekçi, Seval Ürkmez, Seda Özkan |
| 93 |
[GO] |
Biomarkers in Medicine |
2022―Sep―02 |
Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability |
Elba O Medina-Hernández, Lucía M Pérez-Navarro, Joselín Hernández-Ruiz, Alma Villalobos-Osnaya, María L Hernández-Medel, Catalina Casillas-Suárez, Adolfo Pérez-García |
| 94 |
[GO] |
Biomarkers in Medicine |
2022―Sep―02 |
Prognostic value of heparin-binding protein for mortality in severe COVID-19 pneumonia |
Tarık Acar, Birsen Ertekin, Mehmet Yortanlı, Sedat Koçak |
| 95 |
[GO] |
Future Virology |
2022―Aug―31 |
Sudden onset of decreased vision following Delta variant of SARS-CoV-2 infection: a case report |
Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian |
| 96 |
[GO] |
Biomarkers in Medicine |
2022―Aug―25 |
What is the role of prognostic indexes in COVID-19 patients with diabetes mellitus? Data of patients from Turkey |
Safak O Balin, Ulku Kazanci, Kutbeddin Demirdag, Ayhan Akbulut |
| 97 |
[GO] |
Future Virology |
2022―Aug―08 |
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study |
Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey |
| 98 |
[GO] |
Future Microbiology |
2022―Aug―04 |
Follow-up study of anti-SARS-CoV-2 IgG antibody response in COVID-19 patients up to 6 months after infection |
Atalay Eray, Karamese Murat, Gumus Abdullah, Kahraman Ihsan, Kelesoglu Royca, Ozgur Didem, Tutuncu E Ediz |
| 99 |
[GO] |
Future Virology |
2022―Aug―02 |
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy |
Alpo Vuorio, Petri T Kovanen, Frederick Raal |
| 100 |
[GO] |
Future Virology |
2022―Aug―02 |
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations |
Kundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, Kam Y J Zhang, Tomokazu Ohishi, Nik Hirani, Khandu Wadhonkar, Pramod Patidar, Qiuwei Pan, Mirza S Baig |
| 101 |
[GO] |
Personalized Medicine |
2022―Aug―01 |
COVID-19 telehealth preparedness: a cross-sectional assessment of cardiology practices in the USA |
Carly E Waldman, Jean H Min, Heba Wassif, Andrew M Freeman, Anne K Rzeszut, Jack Reilly, Paul Theriot, Ahmed M Soliman, Ritu Thamman, Ami Bhatt, Sanjeev P Bhavnani |
| 102 |
[GO] |
Future Microbiology |
2022―Jul―28 |
Role of the PD-1 and PD-L1 axis in COVID-19 |
Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry |
| 103 |
[GO] |
Future Microbiology |
2022―Jul―28 |
First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria |
Denis Niyazi, Borislava Toncheva, Tsvetan Tonchev, Deyan Dzhenkov, Kalin Kalchev, Temenuga Stoeva |
| 104 |
[GO] |
Future Microbiology |
2022―Jul―28 |
Coinfection with Strongyloides and Ascaris in a COVID-19-positive male presenting with acute abdomen: a case report |
Sweta Singh, Uday S Singh |
| 105 |
[GO] |
Future Microbiology |
2022―Jul―28 |
SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure |
Georgi Merhi, Jad Koweyes, Tamara Salloum, Charbel Al Khoury, Siwar Haidar, Sima Tokajian |
| 106 |
[GO] |
Immunotherapy |
2022―Jul―27 |
Development and characterization of anti-SARS-CoV-2 intravenous immunoglobulin from COVID-19 convalescent plasma |
Mikhail Razumikhin, Tatiana Smolyanova, Alevtina Nikolaeva, Ekaterina Orlova, Aleksandr Ivanov, Olga Belyakova, Tatyana Vyaznikova, Natalia Selezneva, Anton Perevozchikov, Alina Sokolova, Nataliya Zubkova, Irina Efimova, Inna Dolzhikova, Denis Logunov, Elena Sakanjan |
| 107 |
[GO] |
Future Microbiology |
2022―Jul―26 |
G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19 |
Abir Mondal, Soumyadeep Mukherjee, Waseem Dar, Prince Upadhyay, Anand Ranganathan, Soumya Pati, Shailja Singh |
| 108 |
[GO] |
Future Microbiology |
2022―Jul―26 |
Accuracy of Allplex SARS-CoV-2 assay amplification curve analysis for the detection of SARS-CoV-2 variant Alpha |
Tjaša Ž Čretnik, Matjaž Retelj, Sandra Janežič, Aleksander Mahnič, Tine Tesovnik, Robert Šket, Barbara J Bizjan, Samo Jeverica, Mateja Ravnik, Mitja Rak, Mateja Borinc, Maja Rupnik, Tadej Battelino, Marko Pokorn, Jernej Kovač |
| 109 |
[GO] |
Future Virology |
2022―Jul―22 |
Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2 |
Sara Ahmadi Badi, Shohreh Khatami, Seyed Davar Siadat |
| 110 |
[GO] |
Immunotherapy |
2022―Jul―20 |
Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19 |
Ragul Manoharan, Rajshekhar A Kore, Jawahar L Mehta |
| 111 |
[GO] |
Future Virology |
2022―Jul―19 |
A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19 |
Yusuf Emre Ozdemir, Adile Sevde Demir, Meryem Sahin Ozdemir, Busra Mavi, Can Ozen, Hayat Kumbasar Karaosmanoglu |
| 112 |
[GO] |
Immunotherapy |
2022―Jul―19 |
Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report |
Amalia Anastasopoulou, Aikaterini Gkoufa, Panagiotis Diamantopoulos, Spyridon Kazanas, Irene Eliadi, Michael Samarkos, Helen Gogas |
| 113 |
[GO] |
Future Virology |
2022―Jul―19 |
Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? |
Mingmei Zhao, Chunxiao Li, Yu Dong, Xuekun Wang, Wenqing Jiang, Yaogang Chen |
| 114 |
[GO] |
Biomarkers in Medicine |
2022―Jul―14 |
Is there a relationship between epicardial adipose tissue, inflammatory markers and prognosis in COVID-19 in patients under 65 years? |
Emre Emekli, Mustafa H Türkkanı, Sevgi S Ballı |
| 115 |
[GO] |
Immunotherapy |
2022―Jul―05 |
Effectiveness of COVID-19 vaccines against Omicron variant |
Daniel Melo de Oliveira Campos, Maria Karolaynne da Silva, Claudio Bruno Silva de Oliveira, Umberto Laino Fulco, Jonas Ivan Nobre Oliveira |
| 116 |
[GO] |
Immunotherapy |
2022―Jul―05 |
Reply to the letter ‘Effectiveness of COVID-19 vaccines against Omicron variant’ |
Vivek P Chavda, Shailvi Soni, Riddhi Prajapati, Murali M Yallapu, Vasso Apostolopoulos |
| 117 |
[GO] |
Biomarkers in Medicine |
2022―Jul―05 |
Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center |
MK Kalaivani, Shanthi Dinakar |
| 118 |
[GO] |
Future Virology |
2022―Jul―01 |
Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review |
Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan |
| 119 |
[GO] |
Future Virology |
2022―Jul―01 |
SARS-CoV-2 and its repercussive effect on reproductive health: recent trends |
Sukanth Kumar Enmozhi, Jerrine Joseph |
| 120 |
[GO] |
Future Virology |
2022―Jun―28 |
IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report |
Burak Göre, Ezgi Coşkun Yenigün, Şimal Köksal Cevher, Emre Çankaya, Numan Aydın, Fatih Dede |
| 121 |
[GO] |
Future Cardiology |
2022―Jun―23 |
Cardiac resynchronization therapy defibrillator: de novo implant in a COVID-19 patient by an echo-guided axillary venous approach |
Aldo Agea, Maria C Bellino, Domenico Gianfrancesco, Francesco Palma, Giuseppe A Carpagnano, Rita MR Torraco, Maria M Marino, Paola Persichella, Sebastiano Zingaro, Fabio Siena, Roberto Di Tullio, Giovanni Deluca |
| 122 |
[GO] |
Future Oncology |
2022―Jun―20 |
Changing the landscape of European School of Oncology-European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic |
Nicholas Pavlidis, Fedro A Peccatori, Alexandru Eniu, Elie Rassy, Matti Aapro, Franco Cavalli, Florian Lordick, Alberto Costa |
| 123 |
[GO] |
Future Virology |
2022―Jun―16 |
A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program |
Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, Mugdha Tiwari, Hemal Bhalla, Shailendra Goel, Soom Nath Raina |
| 124 |
[GO] |
Future Virology |
2022―Jun―15 |
Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience |
Hakan Apaydin, Abdulsamet Erden, Serdar C Güven, Berkan Armağan, Özlem Karakaş, Bahar Özdemir, Bünyamin Polat, Mehmet Akif Eksin, Ahmet Omma, Orhan Kucuksahin |
| 125 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―Jun―14 |
Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA |
Kayla Engelbrecht, Srinjoy Roy, Gorana Capkun, Kristijan Kahler, Melvin Olson |
| 126 |
[GO] |
Biomarkers in Medicine |
2022―Jun―13 |
Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection |
Pamila Dua, Archana Mishra, KH Reeta |
| 127 |
[GO] |
Immunotherapy |
2022―Jun―13 |
Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report |
Angioletta Lasagna, Marco Vincenzo Lenti, Irene Cassaniti, Paolo Sacchi |
| 128 |
[GO] |
Future Oncology |
2022―Jun―09 |
Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination |
Urska Janzic, Urska Bidovec-Stojkovic, Katja Mohorcic, Loredana Mrak, Nina Fokter Dovnik, Marija Ivanovic, Maja Ravnik, Marina Caks, Erik Skof, Jerneja Debeljak, Peter Korosec, Matija Rijavec |
| 129 |
[GO] |
Future Virology |
2022―Jun―08 |
Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus |
Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Cenk Serhan Ozverel, Emrah Guler, Huseyin Kaya Suer, Murat Sayan, Tamer Sanlidag |
| 130 |
[GO] |
Future Cardiology |
2022―Jun―06 |
Obese patients with long COVID-19 display abnormal hyperventilatory response and impaired gas exchange at peak exercise |
Mickael Rejaudry Lacavalerie, Sandrine Pierre-Francois, Moustapha Agossou, Jocelyn Inamo, André Cabie, José Luis Barnay, Rémi Neviere |
| 131 |
[GO] |
Future Virology |
2022―Jun―03 |
Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India |
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Samantha Vaishnavi, Apekshita Singh, Deepmala Sehgal, Mughdha Tiwari, Shailendra Goel, Soom Nath Raina |
| 132 |
[GO] |
Future Virology |
2022―Jun―03 |
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, Chi Yi Wong, Harikrishnaa Ba Ramaraju, Oswin Chang, Thanansayan Dhivagaran, Zachary Silver |
| 133 |
[GO] |
Biomarkers in Medicine |
2022―May―16 |
Serum hemato-immunological biomarkers associated with increased COVID-19 mortality in the Latino population |
Carla PS Ríos, Oscar GJ Cabrera, Juan JJ-V Whaley, Marisol D Sosa, Victor HA Palacios, Guadalupe LH González, José CJ López |
| 134 |
[GO] |
Biomarkers in Medicine |
2022―May―09 |
Urinary tubular biomarkers as predictors of death in critically ill patients with COVID-19 |
Gabriela F Bezerra, Gdayllon C Meneses, Polianna LMM Albuquerque, Nicole C Lopes, Ranieri SS Santos, Juliana C da Silva, Sandra MB Mota, Rodrigo R Guimarães, Fábio R Guimarães, Álvaro R Guimarães, Caio MC Adamian, Paula R de Lima, Izabel CJ Bandeira, Márcia MP Dantas, Geraldo BS Junior, Reinaldo B Oriá, Elizabeth F Daher, Alice MC Martins |
| 135 |
[GO] |
Future Virology |
2022―May―09 |
Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens |
Forough Tavakoli, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat Mokhtari-Azad |
| 136 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―May―06 |
Economic burden of drug overdose deaths before and during the coronavirus disease 2019 pandemic in the USA |
Briana Lui, Robert S White, Jaime Aaronson, Marguerite Hoyler |
| 137 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―May―05 |
COVID-19 complications in males and females: recent developments |
Rahul Chaturvedi, Briana Lui, Jamie A Aaronson, Robert S White, Jon D Samuels |
| 138 |
[GO] |
Future Microbiology |
2022―May―05 |
Paradox of COVID-19 in pregnancy: are pregnant women more protected against or at elevated risk of severe COVID-19? |
Sheila Santa, Derek A Doku, Charles O Olwal, Charles A Brown, Emmanuel A Tagoe, Osbourne Quaye |
| 139 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―May―05 |
Impact of coronavirus disease 2019 on chronic pain structures: data from French national survey |
Meggane Melchior, Mikhail Dziadzko, Séverine Conradi, Pierrick Poisbeau, Frédéric Aubrun |
| 140 |
[GO] |
Future Microbiology |
2022―May―05 |
Dual targeting of RdRps of SARS-CoV-2 and the mucormycosis-causing fungus: an in silico perspective |
Abdo A Elfiky |
| 141 |
[GO] |
Future Virology |
2022―Apr―26 |
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
Meng Zhang, Yixin Gong, Shunchang Jiao |
| 142 |
[GO] |
Future Microbiology |
2022―Apr―25 |
Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19 |
Malihe Naderi, Seyed Amir Soltani, Akram Taheri Rad, Zahra Mehrbakhsh, Sina Sodagar, Alireza Tahamtan, Seyedeh Sedigheh Hosseini |
| 143 |
[GO] |
Future Microbiology |
2022―Apr―20 |
Clostridioides difficile co-infection in patients with COVID-19 |
Roman Maslennikov, Vladimir Ivashkin, Anna Ufimtseva, Elena Poluektova, Anatoly Ulyanin |
| 144 |
[GO] |
Future Virology |
2022―Apr―19 |
Need for more robust research on the effectiveness of masks in preventing COVID-19 transmission |
Jingjing Nie, Linna Kang, Yaya Pian, Jihong Hu |
| 145 |
[GO] |
Future Virology |
2022―Apr―19 |
Toll-like receptor 4 in COVID-19: friend or foe? |
Suprabhat Mukherjee |
| 146 |
[GO] |
Future Virology |
2022―Apr―11 |
Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus |
Gannon CK Mak, Stephen SY Lau, Kitty KY Wong, Nancy LS Chow, Chi-Shan Lau, Edman TK Lam, Ken HL Ng, Rickjason CW Chan |
| 147 |
[GO] |
Future Oncology |
2022―Apr―06 |
Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic |
Hajer Hadi, Jasmine Handford, Beth Russell, Charlotte L Moss, Maria J Monroy Iglesias, Elke Rammant, Sue Smith, Saoirse Dolly, Kiruthikah Thillai, Anne Rigg, Mieke Van Hemelrijck |
| 148 |
[GO] |
Future Virology |
2022―Apr―05 |
Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus |
Alberto Maria Cattaneo |
| 149 |
[GO] |
Future Virology |
2022―Apr―04 |
In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery |
Amira R Khattab, Mohamed Teleb |
| 150 |
[GO] |
Future Microbiology |
2022―Apr―01 |
Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children |
Danilo Buonsenso, Ferran Espuny Pujol, Daniel Munblit, Davide Pata, Sammie McFarland, Frances K Simpson |
| 151 |
[GO] |
Biomarkers in Medicine |
2022―Mar―30 |
Novel biomarker-based score (SAD-60) for predicting mortality in patients with COVID-19 pneumonia: a multicenter retrospective cohort of 1013 patients |
Serkan Surme, Gulsah Tuncer, Osman F Bayramlar, Betul Copur, Esra Zerdali, Inci Y Nakir, Meltem Yazla, Ahmet Buyukyazgan, Ayse RK Cinar, Yesim Kurekci, Mustafa Alkan, Yusuf E Ozdemir, Gonul Sengoz, Filiz Pehlivanoglu |
| 152 |
[GO] |
Biomarkers in Medicine |
2022―Mar―30 |
Copeptin: a neuroendocrine biomarker of COVID-19 severity |
Reham Hammad, Ahmed Elshafei, Emad Gamil Khidr, Ahmed A El-Husseiny, Maher H Gomaa, Hend G Kotb, Heba H Eltrawy, Hesham Farhoud |
| 153 |
[GO] |
Future Microbiology |
2022―Mar―30 |
Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS-CoV-2 |
Takahiko Koyama, Kei Miyakawa, Reitaro Tokumasu, Sundararaj S Jeremiah, Michiharu Kudo, Akihide Ryo |
| 154 |
[GO] |
Future Rare Diseases |
2022―Mar―30 |
COVID-19 and the rare disease organization response during pandemic: the ‘Italian model’ |
Domenica Taruscio, Annalisa Scopinaro, Giuseppe Limongelli |
| 155 |
[GO] |
Biomarkers in Medicine |
2022―Mar―28 |
Homocysteine as a marker for predicting disease severity in patients with COVID-19 |
Adem Keskin, Goksenin U Ustun, Recai Aci, Utku Duran |
| 156 |
[GO] |
Future Virology |
2022―Mar―21 |
Can anti-parasitic drugs help control COVID-19? |
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, Somayeh Matin, Soheila Molaei |
| 157 |
[GO] |
Immunotherapy |
2022―Mar―21 |
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment |
Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, Anselmo A Abdo Cuza, Yamilka Hernández Sánchez, Aylin Granado Rodríguez, Sarahy Sepúlveda Figueroa, Egda M Llanez Gregorich, Mery L Torres Lahera, Francisco Gómez Peire, Teresita Montero González, Yaneth Zamora González, Ana L Añé Kouri, Addys González Palomo, Mayelin Troche Concepción, Loipa Medel Pérez, Patricia Lorenzo Luaces-Alvarez, Daymys Estévez Iglesias, Danay Saavedra Hernández, Mayra Ramos Suzarte, Tania Crombet Ramos |
| 158 |
[GO] |
Future Virology |
2022―Mar―17 |
A community call to action: mitigating COVID pandemic’s impact on mental health |
Wahid Ullah, Muhammad Ilyas, Mukhtar Alam, Jong Bhak, Peter J Tonellato |
| 159 |
[GO] |
Future Microbiology |
2022―Mar―14 |
Role and perception of clinical microbiology and infectious diseases trainees during the COVID-19 crisis |
Kevin Bouiller, Nathan Peiffer-Smadja, Muge Cevik, Katharina Last, Ivana A Antunović, Anja Šterbenc, Maria J Lopes, Aleksandra Barac, Valentijn Schweitzer, Sarah Dellière |
| 160 |
[GO] |
Future Microbiology |
2022―Mar―14 |
Prediction of putative potential siRNAs for inhibiting SARS-CoV-2 strains, including variants of concern and interest |
Abdullah Al Saba, Maisha Adiba, Sajib Chakraborty, AHM Nurun Nabi |
| 161 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―Mar―10 |
Economic burden of lives lost due to COVID-19 in California State |
Michelle Zheng, Briana Lui, Axell-Giovanni A Komlan, Christina R Bonaparte, Robert S White, Marguerite M Hoyler |
| 162 |
[GO] |
Future Virology |
2022―Mar―08 |
Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation |
Popy Devnath, Md. Jamal Hossain, Talha Bin Emran, Saikat Mitra |
| 163 |
[GO] |
Biomarkers in Medicine |
2022―Mar―02 |
Organ function biomarker abnormalities, associated factors and disease outcome among hospitalized patients with COVID-19 |
Shambel Araya, Yakob G Tsegay, Assegdew Atlaw, Mintsnot Aragaw, Getachew Tadlo, Nebiyu Tsegaye, Daniel Kahase, Zenebe Gebreyohanes, Mollalegne Bitew, Nega Berhane |
| 164 |
[GO] |
Future Virology |
2022―Mar―01 |
Airborne transmission of SARS-CoV-2 disease (COVID-19) |
Mohammad K Parvez, Shama Parveen |
| 165 |
[GO] |
Future Microbiology |
2022―Feb―24 |
Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic |
Sajad Khiali, Elnaz Khani, Samineh B Rouy, Taher Entezari-Maleki |
| 166 |
[GO] |
Biomarkers in Medicine |
2022―Feb―23 |
Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients |
Ákos Nádasdi, György Sinkovits, Ilona Bobek, Botond Lakatos, Zsolt Förhécz, Zita Z Prohászka, Marienn Réti, Miklós Arató, Gellért Cseh, Tamás Masszi, Béla Merkely, Péter Ferdinandy, István Vályi-Nagy, Zoltán Prohászka, Gábor Firneisz |
| 167 |
[GO] |
Immunotherapy |
2022―Feb―21 |
A global picture: therapeutic perspectives for COVID-19 |
Vivek P Chavda, Carron Kapadia, Shailvi Soni, Riddhi Prajapati, Subhash C Chauhan, Murali M Yallapu, Vasso Apostolopoulos |
| 168 |
[GO] |
Future Virology |
2022―Feb―21 |
A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics |
Hanfei Zhang, Feiyang Zhong, Binchen Wang, Meiyan Liao |
| 169 |
[GO] |
Biomarkers in Medicine |
2022―Feb―18 |
Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT |
Roberto M Ferreira, Gabriel SS de Oliveira, João RF da Rocha, Felipe de MC Ribeiro, João J Stern, Rangel de S Costa, Ricardo N Lemgruber, Júlia FP Ramalho, Alexandre CP de Almeida, Pedro PN Sampaio, João Mansur Filho, Ricardo AC Lima |
| 170 |
[GO] |
Future Microbiology |
2022―Feb―15 |
Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic |
Daniele Focosi, Fabrizio Maggi, Scott McConnell, Arturo Casadevall |
| 171 |
[GO] |
Future Virology |
2022―Feb―11 |
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report |
Alireza Ala, Solomon Habtemariam, Samad Shams Vahdati, Aysa Rezabakhsh |
| 172 |
[GO] |
Future Virology |
2022―Feb―10 |
Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19 |
Zhoujie Peng, Jing Zhang, Yuan Shi, Ming Yi |
| 173 |
[GO] |
Future Virology |
2022―Feb―10 |
Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19 |
Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, Orhan Küçükşahin, Ahmet Omma |
| 174 |
[GO] |
Future Virology |
2022―Feb―10 |
Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis |
Serkan Guneyli, Hakan Dogan, Omer Tarik Esengur, Hur Hassoy |
| 175 |
[GO] |
Future Microbiology |
2022―Feb―09 |
Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients |
Sabine Hazan, Sonya Dave, Anoja W Gunaratne, Sibasish Dolai, Robert L Clancy, Peter A McCullough, Thomas J Borody |
| 176 |
[GO] |
Future Oncology |
2022―Feb―07 |
Development and evaluation of a teleoncology system for breast cancer during the COVID-19 pandemic |
Taleb Khodaveisi, Farahnaz Sadoughi, Kambiz Novin, Mohammad Hosseiniravandi, Afsaneh Dehnad |
| 177 |
[GO] |
Future Oncology |
2022―Feb―03 |
SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate |
Alessandro Rizzo, Gennaro Palmiotti |
| 178 |
[GO] |
Future Oncology |
2022―Feb―02 |
An observational study of hospitalized COVID-19 patients with cancer in San Diego county |
David J Hermel, Jason Cham, Samantha R Spierling Bagsic, Lee K Hong, Carrie L Costantini, James R Mason, Alan Saven, Darren S Sigal |
| 179 |
[GO] |
Future Virology |
2022―Jan―31 |
Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Kang Zuo, Elizabeth Lapshina, Madeline Mellett |
| 180 |
[GO] |
Biomarkers in Medicine |
2022―Jan―27 |
Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients |
Mael Padelli, Papa Gueye, Diane Guilloux, Rishika Banydeen, Valentine Campana, Andre Cabie, Remi Neviere |
| 181 |
[GO] |
Future Oncology |
2022―Jan―27 |
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study |
Ayse Irem Yasin, Sabin Göktas Aydin, Bilge Sümbül, Lokman Koral, Melih Şimşek, Çağlayan Geredeli, Akın Öztürk, Perihan Perkin, Derya Demirtaş, Engin Erdemoglu, İlhan Hacıbekiroglu, Emre Çakır, Eda Tanrıkulu, Ezgi Çoban, Melike Ozcelik, Sinemis Çelik, Fatih Teker, Asude Aksoy, Sedat T Fırat, Ömer Tekin, Ziya Kalkan, Orhan Türken, Bala B Oven, Faysal Dane, Ahmet Bilici, Abdurrahman Isıkdogan, Mesut Seker, Hacı M Türk, Mahmut Gümüş |
| 182 |
[GO] |
Future Microbiology |
2022―Jan―19 |
Scrub typhus in two COVID-19 patients: a diagnostic dilemma |
Chandan Kumar Thakur, Priyam Batra, EV Vinayaraj, K Sreenath, Nisha Rathor, Urvashi B Singh, Ridhima Bhatia, Ajisha Aravindan, Naveet Wig, Randeep Guleria, Rama Chaudhry |
| 183 |
[GO] |
Future Microbiology |
2022―Jan―19 |
Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank |
Michael Frank |
| 184 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―Jan―18 |
Impact of telehealth on health care resource utilization during the COVID-19 pandemic |
Prachi Arora, Darshan Mehta, Jane Ha |
| 185 |
[GO] |
Future Oncology |
2022―Jan―17 |
The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer |
Kathryn Tremble, Louis Fox, Charlotte Moss, Beth Russell, Haleema Aljazzaf, Finola Higgins, Bill Dann, Vikash Jogia, Graham Roberts, Anne Rigg, Saoirse Dolly, Mieke Van Hemelrijck |
| 186 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―Jan―13 |
Respiratory and nonrespiratory COVID-19 complications in patients with obesity: recent developments |
Esther Liu, Hudson Lee, Briana Lui, Robert S White, Jon D Samuels |
| 187 |
[GO] |
Epigenomics |
2022―Jan―13 |
The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks |
Milad Shirvaliloo |
| 188 |
[GO] |
Future Virology |
2022―Jan―12 |
Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses |
Jean-François Rossignol |
| 189 |
[GO] |
Future Virology |
2022―Jan―12 |
Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report |
Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour |
| 190 |
[GO] |
Future Oncology |
2022―Jan―12 |
Pattern of breast cancer presentation during the coronavirus disease pandemic: results from a cohort study in the UK |
Kim Borsky, Ketan Shah, Giles Cunnick, Fiona Tsang-Wright |
| 191 |
[GO] |
Nanomedicine |
2022―Jan―11 |
Role of nanomedicine in COVID-19 therapeutics |
Smriti Sharma |
| 192 |
[GO] |
Journal of Comparative Effectiveness Research |
2022―Jan―11 |
Variant analysis of SARS-CoV-2 strains with phylogenetic analysis and the Coronavirus Antiviral and Resistance Database |
Murat Sayan, Ayse Arikan, Murat Isbilen |
| 193 |
[GO] |
Future Microbiology |
2021―Dec―17 |
Role of advanced respiratory support in acute respiratory failure in clinically frail patients with COVID-19 |
Iftikhar Nadeem, Louise Jordon, Masood Ur Rasool, Noor Mahdi, Ritesh Kumar, Zahra Rehman, Craig J Tilley, Simran Kang, Amrita Rai, She Lok, Alison McMillan |
| 194 |
[GO] |
Future Microbiology |
2021―Dec―17 |
Inflammation at the crossroads of Helicobacter pylori and COVID-19 |
Ileana Gonzalez, Cristian Lindner, Ivan Schneider, Miguel A Morales, Armando Rojas |
| 195 |
[GO] |
Future Virology |
2021―Dec―15 |
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 |
Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt |
| 196 |
[GO] |
Future Virology |
2021―Dec―15 |
Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers |
Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak |
| 197 |
[GO] |
Future Virology |
2021―Dec―15 |
Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients |
Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn |
| 198 |
[GO] |
Future Virology |
2021―Dec―06 |
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA |
Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey |
| 199 |
[GO] |
Future Virology |
2021―Dec―03 |
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Oswin Chang, Chi Yi Wong, Zachary Silver |
| 200 |
[GO] |
Neurodegenerative Disease Management |
2021―Dec―02 |
COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report |
Gooya Tayyebi, Seyed Kazem Malakouti, Behnam Shariati, Leila Kamalzadeh |
| 201 |
[GO] |
Future Oncology |
2021―Dec―01 |
Impact of corona-phobia on attitudes and acceptance towards COVID-19 vaccine among cancer patients: a single-center study |
Dilek Erdem, Irem Karaman |
| 202 |
[GO] |
Future Virology |
2021―Nov―26 |
A brief review on DNA vaccines in the era of COVID-19 |
Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, Hamid Tanzadehpanah, Sajad Karampoor, Sima Kazemi, Bahram Yavari, Hanie Mahaki, Mohsen Safaei, Fatemeh Rahbarizadeh, Pouria Samadi, Yaghoub Ahmadyousefi |
| 203 |
[GO] |
Future Virology |
2021―Nov―26 |
Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis |
Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh |
| 204 |
[GO] |
Future Oncology |
2021―Nov―26 |
Clinical and laboratory outcomes of the solid cancer patients reinfected with SARS-CoV-2 |
Oktay Ünsal, Ozan Yazıcı, Nuriye Özdemir, Erdem Çubukçu, Birol Ocak, Aytuğ Üner, Ahmet Özet |
| 205 |
[GO] |
Future Virology |
2021―Nov―26 |
Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran |
Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi |
| 206 |
[GO] |
Future Microbiology |
2021―Nov―23 |
Comparison of clinical, laboratory and radiological features in confirmed and unconfirmed COVID-19 patients |
Serkan Surme, Gulsah Tuncer, Betul Copur, Esra Zerdali, Inci Yilmaz Nakir, Meltem Yazla, Osman Faruk Bayramlar, Ahmet Buyukyazgan, Ayse Ruhkar Kurt Cinar, Hatice Balli, Yesim Kurekci, Filiz Pehlivanoglu, Gonul Sengoz |
| 207 |
[GO] |
Pain Management |
2021―Nov―23 |
Acute worsening of clinical presentation in CRPS after SARS-CoV-2 (COVID-19) vaccination: a case series |
Jessica Zhang, Semih Gungor |
| 208 |
[GO] |
Future Microbiology |
2021―Nov―23 |
Drug-based therapeutic strategies for COVID-19-infected patients and their challenges |
Khatereh Zarkesh, Elaheh Entezar-Almahdi, Parisa Ghasemiyeh, Mohsen Akbarian, Marzieh Bahmani, Shahrzad Roudaki, Rahil Fazlinejad, Soliman Mohammadi-Samani, Negar Firouzabadi, Majid Hosseini, Fatemeh Farjadian |
| 209 |
[GO] |
Immunotherapy |
2021―Nov―22 |
Nimotuzumab for COVID-19: case series |
Anselmo A Abdo Cuza, Jonathan Pi Ávila, Rafael Machado Martínez, José Jordán González, Guillermo Pérez Aspuro, Juan A Gutiérrez Martínez, Mayra Ramos Suzarte, Danay Saavedra Hernández, Ana L Añé-Kouri, Tania Crombet Ramos |
| 210 |
[GO] |
Biomarkers in Medicine |
2021―Nov―17 |
Prognostic Nutritional Index and CRP, age, platelet count, albumin level score in predicting mortality and intensive care unit admission for COVID-19 |
Mehmet Bayram, Ozgur Yildirim, Raye S Ozmen, Beyza Soylu, Ahmet S Dundar, Ali R Koksal, Iskender Ekinci, Murat Akarsu, Omur Tabak |
| 211 |
[GO] |
Biomarkers in Medicine |
2021―Nov―17 |
Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field |
Marília B Visacri, Aline de S Nicoletti, Eder de C Pincinato, Pía Loren, Nicolás Saavedra, Kathleen Saavedra, Luis A Salazar, Patricia Moriel |
| 212 |
[GO] |
Future Virology |
2021―Nov―12 |
Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset |
Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, Fangfei Yang, Zhonghua Qin |
| 213 |
[GO] |
Future Virology |
2021―Nov―12 |
Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy |
Sayantan Laha, Raghunath Chatterjee |
| 214 |
[GO] |
Future Microbiology |
2021―Nov―11 |
Current status of therapeutic approaches and vaccines for SARS-CoV-2 |
Braira Wahid, Anam Amir, Ayesha Ameen, Muhammad Idrees |
| 215 |
[GO] |
Future Microbiology |
2021―Nov―10 |
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV |
Sarah Aherfi, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, Didier Raoult |
| 216 |
[GO] |
Immunotherapy |
2021―Nov―08 |
The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't |
Alexandre E Malek, Paulette Pinargote Cornejo, Nour Daoud, Mohammad Alam |
| 217 |
[GO] |
Future Virology |
2021―Nov―04 |
The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic |
Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi |
| 218 |
[GO] |
Future Virology |
2021―Nov―04 |
In-hospital clinical complications of COVID-19: a brief overview |
Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal |
| 219 |
[GO] |
Future Virology |
2021―Nov―04 |
The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants |
Farid Rahimi, Amin Talebi Bezmin Abadi |
| 220 |
[GO] |
Future Virology |
2021―Nov―04 |
SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system |
Tariq Khan, Syed Muhammad Jamal |
| 221 |
[GO] |
Nanomedicine |
2021―Nov―03 |
Mucoadhesive nanoformulations and their potential for combating COVID-19 |
Parteek Prasher, Mousmee Sharma |
| 222 |
[GO] |
Future Oncology |
2021―Nov―02 |
Factors associated with fatal coronavirus disease 2019 infections among cancer patients in the US FDA Adverse Event Reporting System database |
Omar Abdel-Rahman |
| 223 |
[GO] |
Future Virology |
2021―Oct―29 |
The international treaty for pandemic preparedness and response: same story, different times? |
Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane |
| 224 |
[GO] |
Future Microbiology |
2021―Oct―25 |
Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection |
Muhammad Asif, Mohammad Saleem, Hafiza Sidra Yaseen, Ashwaq HS Yehya, Malik Saadullah, Hafiz Muhammad Zubair, Chern E Oon, Pegah Moradi Khaniabadi, Syed Haroon Khalid, Ikram Ullah Khan |
| 225 |
[GO] |
Future Microbiology |
2021―Oct―22 |
A comparative study of the mental health impact of the COVID-19 pandemic on health care professionals in India |
Jitender Jakhar, Partha Sarathi Biswas, Mahima Kapoor, Amandeep Panghal, Amit Meena, Harsha Fani, Pradip Kharya |
| 226 |
[GO] |
Future Oncology |
2021―Oct―21 |
Urothelial carcinoma in COVID-19: lessons from a pandemic and their impact on clinical practice |
Georges Abi Tayeh, Nour Khalil, Marwan Alkassis, Fouad Aoun, Chady Waked, Elie Nemr |
| 227 |
[GO] |
Biomarkers in Medicine |
2021―Oct―20 |
Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19 |
Selda Murat, Bektas Murat, Muhammet Dural, Gurbet Ozge Mert, Yuksel Cavusoglu |
| 228 |
[GO] |
Biomarkers in Medicine |
2021―Oct―20 |
Plasma endostatin correlates with hypoxia and mortality in COVID-19-associated acute respiratory failure |
Sana Asif, Thoralph Ruge, Anders Larsson, Sara Bülow Anderberg, Miklos Lipcsey, Robert Fritiof, Michael Hultström |
| 229 |
[GO] |
Future Virology |
2021―Oct―19 |
Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity |
Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi |
| 230 |
[GO] |
Personalized Medicine |
2021―Oct―15 |
Personalized therapy: can it tame the COVID-19 monster? |
Mohd Arish, Farha Naz |
| 231 |
[GO] |
Future Virology |
2021―Oct―14 |
Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic |
Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni |
| 232 |
[GO] |
Nanomedicine |
2021―Oct―11 |
Nano-carriers of COVID-19 vaccines: main pillars of efficacy |
Carolina Constantin, Anissa Pisani, Giuseppe Bardi, Monica Neagu |
| 233 |
[GO] |
Personalized Medicine |
2021―Oct―08 |
Intelligent health system for investigation and consenting COVID-19 patients and precision medicine |
Zeeshan Ahmed |
| 234 |
[GO] |
Future Virology |
2021―Oct―08 |
Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? |
Lei Huang |
| 235 |
[GO] |
Future Virology |
2021―Oct―08 |
A case series of pediatric COVID-19 with complicated symptoms in Iran |
Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, Somayeh Shahabi, Alijan Tabarraei, Alireza Tahamtan |
| 236 |
[GO] |
Future Microbiology |
2021―Oct―07 |
Molecular characterization, phylogenetic and variation analyses of SARS-CoV-2 strains in Turkey |
Murat Karamese, Didem Ozgur, Emin E Tutuncu |
| 237 |
[GO] |
Pain Management |
2021―Oct―04 |
Myofascial pain syndrome and SARS-CoV-2: a case series |
Jaldhi Patel, Saba Javed |
| 238 |
[GO] |
Immunotherapy |
2021―Sep―29 |
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research |
Angioletta Lasagna, Marta Muzzana, Paolo Pedrazzoli |
| 239 |
[GO] |
Future Virology |
2021―Sep―22 |
Association between blood groups and COVID-19 outcome in Iranian patients |
Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, Abdolhalim Rajabi, Alireza Tahamtan |
| 240 |
[GO] |
Future Virology |
2021―Sep―21 |
High-value laboratory testing for hospitalized COVID-19 patients: a review |
Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, Kieren A Marr, Andrew H Karaba, Matthew L Robinson, Paul W Blair, Maria V Dioverti, Wendy S Post, Andrea L Cox, Annukka A R Antar |
| 241 |
[GO] |
Biomarkers in Medicine |
2021―Sep―20 |
Prospective selected biomarkers in COVID-19 diagnosis and treatment |
Tahani Tabassum, Ahsab Rahman, Yusha Araf, Md A Ullah, Mohammad J Hosen |
| 242 |
[GO] |
Future Virology |
2021―Sep―10 |
Fast evolution of SARS-CoV-2 driven by deamination systems in hosts |
Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, Wenqing Jiang, Bin Yin |
| 243 |
[GO] |
Future Oncology |
2021―Sep―03 |
Predictors of poor precautionary practices towards COVID-19 among cancer patients |
Abdul R Jazieh, Assia A Bensalem, Adda Bounedjar, Zineb Benbrahim, Mohamed O Alorabi, Atlal M Abusanad, Emad M Tashkandi, Muath AMA Alnassar, Abdul RAD El Kinge, Sana Al-Sukhun, Abdullah Alsharm, Hassan Errihani, Nafisa A Abdelhafiez, Mohammad Alkaiyat, Hoda Jradi |
| 244 |
[GO] |
Future Cardiology |
2021―Sep―03 |
COVID-19, cardiovascular diseases and cardiac troponins |
Chan W Kim, Wilbert S Aronow |
| 245 |
[GO] |
Future Virology |
2021―Sep―02 |
Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 |
Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh |
| 246 |
[GO] |
Biomarkers in Medicine |
2021―Sep―02 |
Emerging treatments for COVID-19: déjà vu all over again? |
Ricardo AC Lima, Roberto M Ferreira |
| 247 |
[GO] |
Future Virology |
2021―Sep―02 |
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors |
Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut |
| 248 |
[GO] |
Future Microbiology |
2021―Sep―01 |
Coronaviruses construct an interconnection way with ERAD and autophagy |
Aref Movaqar, Atieh Yaghoubi, SA Rahim Rezaee, Saeid A Jamehdar, Saman Soleimanpour |
| 249 |
[GO] |
Future Microbiology |
2021―Sep―01 |
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses |
Sirio Fiorino, Fabio Tateo, Dario De Biase, Claudio G Gallo, Paolo E Orlandi, Ivan Corazza, Roberta Budriesi, Matteo Micucci, Michela Visani, Elisabetta Loggi, Wandong Hong, Roberta Pica, Federico Lari, Maddalena Zippi |
| 250 |
[GO] |
Journal of Comparative Effectiveness Research |
2021―Aug―31 |
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations |
Stephanie H Read, Artak Khachatryan, Aastha Chandak, Roman Casciano, Paul Hodgkins, Richard Haubrich, Essy Mozaffari |
| 251 |
[GO] |
Immunotherapy |
2021―Aug―25 |
Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis |
Wenwei Qian, Ying Ye, Lugen Zuo, Ting Song, Qing Xu, Yinghong Wang, Jun Qian, Yun Tian |
| 252 |
[GO] |
Future Oncology |
2021―Aug―25 |
Thyroid cancer surgery during the coronavirus disease 2019 pandemic: perioperative management and oncological and anatomical considerations |
Eleftherios Spartalis, Nikolaos Plakopitis, Maria Anna Theodori, Sotirios P Karagiannis, Dimitrios I Athanasiadis, Michael Spartalis, Georgios Boutzios, Stavroula A Paschou, Nikolaos Nikiteas, Theodore Troupis |
| 253 |
[GO] |
Nanomedicine |
2021―Aug―25 |
Carbon nanomaterials as promising substrates in the design of sensors for SARS-CoV-2 and new emerging viral infections |
Sepideh Abbaszadeh, Ghazal Nikaeen, Saeed Yousefinejad |
| 254 |
[GO] |
Biomarkers in Medicine |
2021―Aug―18 |
Usefulness of C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in SARS coronavirus-2 |
Saban Kelesoglu, Yucel Yilmaz, Eyup Ozkan, Bekir Calapkorur, Zehra B Dursun, Aysegul Ulu-Kilic, Deniz Elcık |
| 255 |
[GO] |
Future Virology |
2021―Aug―09 |
Harnessing immunological targets for COVID-19 immunotherapy |
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu |
| 256 |
[GO] |
Journal of 3D Printing in Medicine |
2021―Aug―09 |
Industrial applications of 3D printing to scale-up production of COVID-19-related medical equipment |
Muhammad Zaheer Abbas |
| 257 |
[GO] |
Future Virology |
2021―Jul―29 |
Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients |
Gerald Chi, Sahar Memar Montazerin, Jane J Lee |
| 258 |
[GO] |
Future Microbiology |
2021―Jul―28 |
Relationship of D-dimer and prediction of pulmonary embolism in hospitalized COVID-19 patients: a multicenter study |
Iftikhar Nadeem, Asad Anwar, Louise Jordon, Noor Mahdi, Masood Ur Rasool, Jonathan Dakin, She Lok |
| 259 |
[GO] |
Future Microbiology |
2021―Jul―28 |
Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future? |
Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi, Lydia Mosi |
| 260 |
[GO] |
Future Oncology |
2021―Jul―22 |
Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic |
Ayse Irem Yasin, Atakan Topcu, Abdallah TM Shbair, Zehra Sucuoglu Isleyen, Ahmet Ozturk, Mehmet Besiroglu, Hacı Mehmet Türk |
| 261 |
[GO] |
Biomarkers in Medicine |
2021―Jul―21 |
National Early Warning Score 2 and laboratory predictors correlate with clinical deterioration in hospitalized patients with COVID-19 |
Gulsah Tuncer, Serkan Surme, Osman F Bayramlar, Hatice K Karanalbant, Betul Copur, Meltem Yazla, Esra Zerdali, Inci Y Nakir, Ayse RK Cinar, Ahmet Buyukyazgan, Hatice Balli, Yesim Kurekci, Serap Simsek-Yavuz, Mehmet M Sonmez, Gonul Sengoz, Filiz Pehlivanoglu |
| 262 |
[GO] |
Neurodegenerative Disease Management |
2021―Jul―21 |
A survey on patients' disease perception and the impact of the COVID-19 pandemic on persons living with amyotrophic lateral sclerosis in Malaysia |
Suzanna Edgar, Nur Adilah Abdul-Aziz, Ee Chin Loh, David Capelle, Khean-Jin Goh, Lydia Abdul Latif, Nortina Shahrizaila, Azlina Ahmad-Annuar |
| 263 |
[GO] |
Future Virology |
2021―Jul―20 |
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation |
Claudia Cava, Gloria Bertoli, Isabella Castiglioni |
| 264 |
[GO] |
Future Virology |
2021―Jul―20 |
An overview of sex hormones in relation to SARS-CoV-2 infection |
Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani |
| 265 |
[GO] |
Future Virology |
2021―Jul―20 |
In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database |
Eldar Muhtar, Mengyang Wang, Haimei Zhu |
| 266 |
[GO] |
Future Oncology |
2021―Jul―19 |
Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub |
Stefano Luzzago, Francesco A Mistretta, Enza Dossena, Gianna Comandi, Giovanni Petralia, Dario Di Trapani, Gabriele Cozzi, Antonio Galfano, Matteo Ferro, Aldo M Bocciardi, Gennaro Musi, Ottavio de Cobelli |
| 267 |
[GO] |
Future Oncology |
2021―Jul―15 |
Cancer and COVID-19: analysis of patient outcomes |
Mohamed Aboueshia, Mohammad Hosny Hussein, Abdallah S Attia, Aubrey Swinford, Peter Miller, Mahmoud Omar, Eman Ali Toraih, Nakhle Saba, Hana Safah, Juan Duchesne, Emad Kandil |
| 268 |
[GO] |
Journal of 3D Printing in Medicine |
2021―Jul―13 |
Use of 3D printing to support COVID-19 medical supply shortages: a review |
Stephanie Ishack, Shari R Lipner |
| 269 |
[GO] |
Future Virology |
2021―Jul―13 |
Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study |
Ajita Pandey, Mohit Sharma |
| 270 |
[GO] |
Future Oncology |
2021―Jul―13 |
Is obesity a risk factor in cancer patients with COVID-19? |
Robin Park, Elizabeth Wulff-Burchfield, Weijing Sun, Anup Kasi |
| 271 |
[GO] |
Future Virology |
2021―Jul―13 |
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective |
Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh |
| 272 |
[GO] |
Future Virology |
2021―Jul―08 |
Association of anemia and COVID-19 in hospitalized patients |
Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng |
| 273 |
[GO] |
Epigenomics |
2021―Jul―06 |
Implication of epitranscriptomics in trained innate immunity and COVID-19 |
Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan |
| 274 |
[GO] |
Future Virology |
2021―Jul―06 |
Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 |
Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu |
| 275 |
[GO] |
Future Microbiology |
2021―Jul―05 |
Prevalence of COVID-19 in 10,000 samples from 7853 patients in Eastern Turkey by positive real-time PCR |
Murat Karamese, Didem Ozgur, Ceyda Tarhan, Susamber D Altintas, Okan Caliskan, Aysegul Tuna, Saliha Kazci, Mursel Karadavut, Abdullah Gumus, Gozde Apaydin, Necati Mumcu, Onur Coruh, Emin E Tutuncu |
| 276 |
[GO] |
Future Oncology |
2021―Jun―30 |
Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination |
Bangyu Luo, Jixi Li, Xianhua Hou, Qiao Yang, Yi Zhou, Jun Ye, Xiaocheng Wu, Yimei Feng, Tianyu Hu, Zhi Xu, Ying He, Jianguo Sun |
| 277 |
[GO] |
Future Virology |
2021―Jun―30 |
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan |
| 278 |
[GO] |
Future Microbiology |
2021―Jun―24 |
Amuchina Gel Xgerm hand rub in vitro virucidal activity against SARS-CoV-2 |
Alessandra Capezzone de Joannon, Angela Testa, Natalie Falsetto, Michela Procaccini, Lorella Ragni |
| 279 |
[GO] |
Future Virology |
2021―Jun―22 |
The COVID-19 pandemic: an increased risk of rheumatoid arthritis |
Archana Tripathy, Nitish Swain, Bhawna Gupta |
| 280 |
[GO] |
Future Virology |
2021―Jun―22 |
V483A: an emerging mutation hotspot of SARS-CoV-2 |
Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque |
| 281 |
[GO] |
Future Virology |
2021―Jun―22 |
Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates |
Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing |
| 282 |
[GO] |
Pharmacogenomics |
2021―Jun―18 |
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes |
S Sahana, Ambily Sivadas, Mohit Mangla, Abhinav Jain, Rahul C Bhoyar, Kavita Pandhare, Anushree Mishra, Disha Sharma, Mohamed Imran, Vigneshwar Senthivel, Mohit Kumar Divakar, Mercy Rophina, Bani Jolly, Arushi Batra, Sumit Sharma, Sanjay Siwach, Arun G Jadhao, Nikhil V Palande, Ganga Nath Jha, Nishat Ashrafi, Prashant Kumar Mishra, AK Vidhya, Suman Jain, Debasis Dash, Nachimuthu Senthil Kumar, Andrew Vanlallawma, Ranjan Jyoti Sarma, Lalchhandama Chhakchhuak, Shantaraman Kalyanaraman, Radha Mahadevan, Sunitha Kandasamy, Pabitha Devi, Raskin Erusan Rajagopal, J Ezhil Ramya, P Nirmala Devi, Anjali Bajaj, Vishu Gupta, Samatha Mathew, Sangam Goswami, Savinitha Prakash, Kandarp Joshi, Meya Kumla, S Sreedevi, Devarshi Gajjar, Ronibala Soraisham, Rohit Yadav, Yumnam Silla Devi, Aayush Gupta, Mitali Mukerji, Sivaprakash Ramalingam, BK Binukumar, Sridhar Sivasubbu, Vinod Scaria |
| 283 |
[GO] |
Regenerative Medicine |
2021―Jun―11 |
Anticipated impact of stem cell and other cellular medicine clinical trials for COVID-19 |
Mina Kim, Paul S Knoepfler |
| 284 |
[GO] |
Immunotherapy |
2021―Jun―11 |
Appropriate use of antimicrobial therapy for COVID-19 co-infection |
Chih-Cheng Lai, Wen-Liang Yu |
| 285 |
[GO] |
Future Oncology |
2021―Jun―09 |
Telehealth amid the COVID19 pandemic: perception among Asian, Native Hawaiian and Pacific Islander cancer patients |
Michael Meno, Justin Abe, Jami Fukui, Christa Braun-Inglis, Ian Pagano, Jared Acoba |
| 286 |
[GO] |
Future Microbiology |
2021―Jun―04 |
Clinical microbiology laboratories and COVID-19: an interview with Joseph Blondeau |
Joseph Blondeau |
| 287 |
[GO] |
Personalized Medicine |
2021―Jun―04 |
Pharmacogenomic considerations for repurposing of dexamethasone as a potential drug against SARS-CoV-2 infection |
Manik Vohra, Anu Radha Sharma, Kapaettu Satyamoorthy, Padmalatha S Rai |
| 288 |
[GO] |
Journal of Comparative Effectiveness Research |
2021―Jun―01 |
Economic burden of lives lost due to COVID-19 in New York State |
Briana Lui, Michelle Zheng, Robert S White, Marguerite Hoyler |
| 289 |
[GO] |
Future Virology |
2021―Jun―01 |
Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery |
Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar |
| 290 |
[GO] |
Nanomedicine |
2021―May―28 |
Special Focus Issue - Applications of nanotechnology against COVID-19: a special focus issue by Nanomedicine |
Alice Bough |
| 291 |
[GO] |
Future Virology |
2021―May―24 |
Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series |
Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong |
| 292 |
[GO] |
Future Virology |
2021―May―19 |
Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time |
Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang |
| 293 |
[GO] |
Future Virology |
2021―May―19 |
SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses |
Andrew P Rice, Jason T Kimata |
| 294 |
[GO] |
Future Microbiology |
2021―May―17 |
Preventing the next pandemic and tackling antiscience: an interview with Peter Hotez |
Peter Hotez |
| 295 |
[GO] |
Nanomedicine |
2021―May―17 |
Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation |
Priya Singh, Deepika Singh, Pratikshya Sa, Priyanka Mohapatra, Auromira Khuntia, Sanjeeb K Sahoo |
| 296 |
[GO] |
Biomarkers in Medicine |
2021―May―14 |
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings |
Salvatore Fuschillo, Pasquale Ambrosino, Andrea Motta, Mauro Maniscalco |
| 297 |
[GO] |
Regenerative Medicine |
2021―May―14 |
Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy? |
Gaia Spinetti, Elisa Avolio, Paolo Madeddu |
| 298 |
[GO] |
Biomarkers in Medicine |
2021―May―14 |
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience |
Eman Farid, Kannan Sridharan, Ola AM Alsegai, Safa Al Khawaja, Eman J Mansoor, Noor A Teraifi, Manaf Al Qahtani, Jameela Al Salman |
| 299 |
[GO] |
Nanomedicine |
2021―May―14 |
Nanoscale pathogens treated with nanomaterial-like peptides: a platform technology appropriate for future pandemics |
Alaa F Nahhas, Alrayan F Nahhas, Thomas J Webster |
| 300 |
[GO] |
Nanomedicine |
2021―May―13 |
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro |
Richa Vartak, Suyash M Patil, Aishwarya Saraswat, Manali Patki, Nitesh K Kunda, Ketan Patel |
| 301 |
[GO] |
Future Virology |
2021―May―12 |
Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission |
Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, Ayse K Kalem, Mustafa Özdemir, Necati Y Yeşilova, Emra A Kalkan, Musa Civak, Orhan Kücüksahin, Abdulsamet Erden, Ihsan Ates |
| 302 |
[GO] |
Journal of 3D Printing in Medicine |
2021―May―11 |
3D printing in surgical simulation: emphasized importance in the COVID-19 pandemic era |
Ross Michaels, Chelsey A Witsberger, Allison R Powell, Krishna Koka, Katheryn Cohen, Zahra Nourmohammadi, Glen E Green, David A Zopf |
| 303 |
[GO] |
Nanomedicine |
2021―May―11 |
How has nanomedical innovation contributed to the COVID-19 vaccine development? |
João Paulo Figueiró Longo, Luis Alexandre Muehlmann |
| 304 |
[GO] |
Future Microbiology |
2021―May―11 |
Metabolite reanalysis revealed potential biomarkers for COVID-19: a potential link with immune response |
Xin Chen, Mingli Gu, Tengda Li, Yi Sun |
| 305 |
[GO] |
Nanomedicine |
2021―May―11 |
Nanotechnology-based self-sterilizing surfaces and their potential in combating coronavirus disease 2019 |
Parteek Prasher, Mousmee Sharma |
| 306 |
[GO] |
Future Microbiology |
2021―May―07 |
Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes |
Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanasios Tsakris |
| 307 |
[GO] |
Journal of 3D Printing in Medicine |
2021―May―05 |
The role of 3D printing in the fight against COVID-19 outbreak |
Payar Radfar, Sajad Razavi Bazaz, Fateme Mirakhorli, Majid Ebrahimi Warkiani |
| 308 |
[GO] |
Immunotherapy |
2021―Apr―28 |
Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i) |
Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante |
| 309 |
[GO] |
Future Virology |
2021―Apr―26 |
An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach |
Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh |
| 310 |
[GO] |
Journal of Comparative Effectiveness Research |
2021―Apr―23 |
Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia |
Mehmet Agirbasli, Azra Tanrıkulu |
| 311 |
[GO] |
Future Virology |
2021―Apr―22 |
HIV and COVID-19 pandemic collision: turning challenges into opportunity |
Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli |
| 312 |
[GO] |
Future Virology |
2021―Apr―21 |
Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia |
Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram |
| 313 |
[GO] |
Future Cardiology |
2021―Apr―20 |
Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor |
Daanyaal Wasim, Bjørn Alme, Stina Jordal, Tomas Mikal Lind Eagan, Marijana Tadic, Giuseppe Mancia, Anne Berit Guttormsen, Sahrai Saeed |
| 314 |
[GO] |
Epigenomics |
2021―Apr―20 |
Epigenomics in COVID-19; the link between DNA methylation, histone modifications and SARS-CoV-2 infection |
Milad Shirvaliloo |
| 315 |
[GO] |
Future Virology |
2021―Apr―14 |
The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period |
Hamid Tayebi Khosroshahi, Alireza Mardomi |
| 316 |
[GO] |
Future Microbiology |
2021―Apr―13 |
Herd immunity: could it bring the COVID-19 pandemic to an end? |
Thomas Hugh Pennington |
| 317 |
[GO] |
Future Microbiology |
2021―Apr―13 |
The interplay of SARS-CoV-2 and Clostridioides difficile infection |
Sahil Khanna, Colleen S Kraft |
| 318 |
[GO] |
Future Virology |
2021―Apr―07 |
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients |
Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, Shaoqian Cai, Kaiwen Guo, Qiang Wang, Xiaoliu Liu, Qingming Wu |
| 319 |
[GO] |
Future Virology |
2021―Apr―06 |
Xerostomia (dry mouth) in patients with COVID-19: a case series |
Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi |
| 320 |
[GO] |
Biomarkers in Medicine |
2021―Mar―29 |
Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19 |
Zhikun Zeng, Xiao-Yue Hong, Yunhui Li, Wei Chen, Guangming Ye, Yirong Li, Yi Luo |
| 321 |
[GO] |
Future Virology |
2021―Mar―25 |
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach |
Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee |
| 322 |
[GO] |
Journal of 3D Printing in Medicine |
2021―Mar―24 |
COVID-19 and the worldwide actions to mitigate its effects using 3D printing |
Guilherme Arthur Longhitano, Jorge Vicente Lopes da Silva |
| 323 |
[GO] |
Future Virology |
2021―Mar―24 |
The role of miRNAs in COVID-19 disease |
Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi |
| 324 |
[GO] |
Pharmacogenomics |
2021―Mar―24 |
Predictive association of ABCB1 C3435T genetic polymorphism with the efficacy or safety of lopinavir and ritonavir in coronavirus disease-2019 patients |
Mohitosh Biswas |
| 325 |
[GO] |
Future Cardiology |
2021―Mar―19 |
SARS-CoV-2 as an inflammatory cardiovascular disease: current knowledge and future challenges |
Kevin S Shah, Mary Elizabeth Hale Hammond, Stavros G Drakos, Jeffrey L Anderson, James C Fang, Kirk U Knowlton, Robin M Shaw |
| 326 |
[GO] |
Future Microbiology |
2021―Mar―12 |
COVID-19 pneumonia: do not leave the corticosteroids behind! |
Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa |
| 327 |
[GO] |
Video Journal of Biomedicine |
2021―Mar―11 |
Managing colorectal cancer patients in the COVID-19 era: international discussion on the role of precision medicine in triaging patients |
|
| 328 |
[GO] |
Epigenomics |
2021―Mar―09 |
An immune epigenetic insight to COVID-19 infection |
Bimal P Jit, Sahar Qazi, Rakesh Arya, Ankit Srivastava, Nimesh Gupta, Ashok Sharma |
| 329 |
[GO] |
Future Virology |
2021―Mar―09 |
Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report |
Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi |
| 330 |
[GO] |
Nanomedicine |
2021―Mar―08 |
Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives |
Hamid Rashidzadeh, Hossein Danafar, Hossein Rahimi, Faezeh Mozafari, Marziyeh Salehiabar, Mohammad Amin Rahmati, Samaneh Rahamooz-Haghighi, Navid Mousazadeh, Ali Mohammadi, Yavuz Nuri Ertas, Ali Ramazani, Irada Huseynova, Rovshan Khalilov, Soodabeh Davaran, Thomas J Webster, Taras Kavetskyy, Aziz Eftekhari, Hamed Nosrati, Mehdi Mirsaeidi |
| 331 |
[GO] |
Future Virology |
2021―Mar―08 |
Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity |
Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari |
| 332 |
[GO] |
Biomarkers in Medicine |
2021―Mar―05 |
Biomarkers to safely discharge head trauma patients in the COVID-19 pandemic era |
George A Alexiou, Georgios D Lianos, Eleftherios-Spyridon Alexiou, Spyridon Voulgaris |
| 333 |
[GO] |
Future Virology |
2021―Mar―02 |
Computational guided approach for drug repurposing against SARS-CoV-2 |
Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai |
| 334 |
[GO] |
Future Oncology |
2021―Feb―26 |
Patient satisfaction with telemedicine for prechemotherapy evaluation during the COVID-19 pandemic |
Ajithraj Sathiyaraj, Hannah Lopez, Rakesh Surapaneni |
| 335 |
[GO] |
Future Virology |
2021―Feb―24 |
Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany |
Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, Ahmed Ghazy, Mohamed Maged Nagaty Ibrahim, Mostafa Ebraheem Morra |
| 336 |
[GO] |
Future Virology |
2021―Feb―22 |
Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition |
Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti |
| 337 |
[GO] |
Journal of Comparative Effectiveness Research |
2021―Feb―17 |
Estimates of the value of life lost from COVID-19 in Ohio |
Peter J Mallow |
| 338 |
[GO] |
Future Cardiology |
2021―Feb―12 |
Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors |
Milad Shirvaliloo |
| 339 |
[GO] |
Future Microbiology |
2021―Feb―11 |
Dual targeting of toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment |
Laura Kate Gadanec, Tawar Qaradakhi, Kristen R McSweeney, Benazir Ali, Anthony Zulli, Vasso Apostolopoulos |
| 340 |
[GO] |
Immunotherapy |
2021―Feb―09 |
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma |
Shaukat Ali, Syed M Uddin, Ayesha Ali, Fatima Anjum, Rashid Ali, Elisha Shalim, Mujtaba Khan, Iqra Ahmed, Sheikh M Muhaymin, Uzma Bukhari, Shobha Luxmi, Abdul S Khan, Saeed Quraishy |
| 341 |
[GO] |
Future Virology |
2021―Feb―09 |
The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days |
Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, Wataru Kamitani, Masanobu Yamada |
| 342 |
[GO] |
Future Oncology |
2021―Feb―04 |
The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients |
Melissa Bersanelli, Diana Giannarelli, Alessandro Leonetti, Sebastiano Buti, Marcello Tiseo, Antonio Nouvenne, Andrea Ticinesi, Tiziana Meschi, Giuseppe Procopio, Riccardo Danielli |
| 343 |
[GO] |
Future Virology |
2021―Feb―04 |
What is the intermediate host species of SARS-CoV-2? |
Thomas Friend, Justin Stebbing |
| 344 |
[GO] |
Future Oncology |
2021―Feb―03 |
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit |
Pietro Quaglino, Paolo Fava, Matteo Brizio, Elena Marra, Marco Rubatto, Martina Merli, Luca Tonella, Simone Ribero, Maria Teresa Fierro |
| 345 |
[GO] |
Future Virology |
2021―Feb―03 |
SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges |
Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag |
| 346 |
[GO] |
Journal of 3D Printing in Medicine |
2021―Feb―02 |
3D-printed valves to assist noninvasive ventilation procedures during the COVID-19 pandemic: a case study |
Guilherme Arthur Longhitano, Geovany Candido, Leonardo Mendes Ribeiro Machado, Paulo Inforçatti Neto, Marcelo Fernandes de Oliveira, Pedro Yoshito Noritomi, Francisco Guilherme Mais, Victor Luiz de Paula Souza, Jorge Vicente Lopes da Silva |
| 347 |
[GO] |
Future Virology |
2021―Jan―28 |
Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran |
Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, Somayeh Mousavi, Sama Faramarzi, Armin Farhang, Shaghayegh Haghjooy Javanmard, Mehrdad Salahi, Ali Darakhshandeh, Kazem Ahmadikia, Hossein Mirhendi |
| 348 |
[GO] |
Biomarkers in Medicine |
2021―Jan―27 |
Evaluation of the relation between cardiac biomarkers and thorax computerized tomography findings in COVID-19 patients |
Cigdem Ileri, Zekeriya Dogan, Beste Ozben, Cagla Karaoglu, Nuran Gunay, Kursat Tigen, Sema Basat, Cihangir Uyan |
| 349 |
[GO] |
Future Virology |
2021―Jan―26 |
Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 |
Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, Jing Wang, Xuemei Jiang, Yun Zhang, Yuling Han, Zhongfa Zhang, Zhongtao Gai |
| 350 |
[GO] |
Future Virology |
2021―Jan―25 |
Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran |
Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, Iraj Nabipour, Amirhossein Darabi, Saeid Keshmiri |
| 351 |
[GO] |
Future Microbiology |
2021―Jan―25 |
COVID-19: it is all about sepsis |
Jean-Louis Vincent |
| 352 |
[GO] |
Future Microbiology |
2021―Jan―19 |
Review of the use of nasal and oral antiseptics during a global pandemic |
Christopher Stathis, Nikolas Victoria, Kristin Loomis, Shaun A Nguyen, Maren Eggers, Edward Septimus, Nasia Safdar |
| 353 |
[GO] |
Future Microbiology |
2021―Jan―18 |
The histo-blood group antigens of the host cell may determine the binding of different viruses such as SARS-CoV-2 |
Mayra Cuéllar-Cruz |
| 354 |
[GO] |
Future Virology |
2021―Jan―13 |
Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome |
María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini |
| 355 |
[GO] |
Future Virology |
2021―Jan―07 |
A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols |
Michael L Hitchman |
| 356 |
[GO] |
Future Microbiology |
2021―Jan―06 |
Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients |
Reza Ghanbari, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, Abolghasem Jouyban, Susan CJ Sumner |
| 357 |
[GO] |
Future Microbiology |
2021―Jan―06 |
Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance? |
Kesego Tapela, Charles Ochieng’ Olwal, Osbourne Quaye |
| 358 |
[GO] |
Immunotherapy |
2021―Jan―05 |
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases |
Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Jorge Alain Caballero, Naivy Sánchez, Jorge Berrio, Geidy Lorenzo, Meylan Cepeda, Mayra Ramos, Danay Saavedra, Ana Laura Añe-Kouri, Zaima Mazorra, Kalet Leon, Tania Crombet, Armando Caballero |
| 359 |
[GO] |
Future Virology |
2020―Dec―24 |
Relationship between IL-6 and COVID-19: to be considered during treatment |
Hafize Seda Vatansever, Eda Becer |
| 360 |
[GO] |
Future Microbiology |
2020―Dec―22 |
COVID-19: mask efficacy is dependent on both fabric and fit |
Steven Darby, Krishnakumar Chulliyallipalil, Milosz Przyjalgowski, Paddy McGowan, Simon Jeffers, Alan Giltinan, Liam Lewis, Niall Smith, Roy D Sleator |
| 361 |
[GO] |
Future Cardiology |
2020―Dec―17 |
A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia |
Luigi Cappannoli, Alessandro Telesca, Roberto Scacciavillani, Edoardo Petrolati, Andrea Smargiassi, Alessia Rabini, Massimo Massetti, Filippo Crea, Nadia Aspromonte |
| 362 |
[GO] |
Future Oncology |
2020―Dec―17 |
TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the coronavirus disease 2019 pandemic |
Ziyao Wang, YaNan Kang, FuRong Yu, Feng-Hui Zhong, Kangni Huang, Xuan Zhou, Yunrong Tang, Yu Zhang, Yu-Ligh Liou, Yan Ma |
| 363 |
[GO] |
Future Virology |
2020―Dec―16 |
Pandemic response management framework based on efficiency of COVID-19 control and treatment |
Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi |
| 364 |
[GO] |
Future Virology |
2020―Dec―15 |
Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? |
Yashwant Kumar, Reena Yadav, Alka Bhatia |
| 365 |
[GO] |
Immunotherapy |
2020―Dec―14 |
Immunity to glycan α-Gal and possibilities for the control of COVID-19 |
José de la Fuente, Christian Gortázar, Alejandro Cabezas-Cruz |
| 366 |
[GO] |
Journal of 3D Printing in Medicine |
2020―Dec―07 |
COVID-19: additive manufacturing response in the UK |
Elen J Parry, Craig E Banks |
| 367 |
[GO] |
Nanomedicine |
2020―Dec―03 |
New proposal involving nanoformulated melatonin targeted to the mitochondria as a potential COVID-19 treatment |
Virna Margarita Martín Giménez, Natalia Prado, Emiliano Diez, Walter Manucha, Russel J Reiter |
| 368 |
[GO] |
Future Oncology |
2020―Dec―02 |
‘Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer?’ Retraction notice |
|
| 369 |
[GO] |
Future Oncology |
2020―Dec―02 |
Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience |
Christine Salem, Marie-Ange Hajj, Hampig Kourié, Antoine Haddad, Abir Khaddage, Eliane Nasser Ayoub, Khalil Jabbour, Malak Moubarak, David Atallah |
| 370 |
[GO] |
Journal of 3D Printing in Medicine |
2020―Dec―01 |
Pivoting: from academic 3D printing to rapid COVID-19 solutions |
Allison R Powell, Charles A Keilin, Ross E Michaels, Owen J Tien, Kyle K VanKoevering, Glenn E Green, David A Zopf |
| 371 |
[GO] |
Journal of 3D Printing in Medicine |
2020―Dec―01 |
Potential risks of a widespread use of 3D printing for the manufacturing of face masks during the severe acute respiratory syndrome coronavirus 2 pandemic |
Sven Duda, Sascha Hartig, Karola Hagner, Lisa Meyer, Paula Wessling Intriago, Tobias Meyer, Heinrich Wessling |
| 372 |
[GO] |
Future Virology |
2020―Nov―30 |
Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India |
Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig |
| 373 |
[GO] |
Future Oncology |
2020―Nov―27 |
COVID-19 and breast cancer: may the microbiome be the issue? |
Angioletta Lasagna, Valentina Zuccaro, Elisa Ferraris, Marta Corbella, Raffaele Bruno, Paolo Pedrazzoli |
| 374 |
[GO] |
Future Oncology |
2020―Nov―27 |
In reply to the Letter to the Editor on: telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities |
Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie |
| 375 |
[GO] |
Pharmacogenomics |
2020―Nov―27 |
Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2 mediated SARS-CoV-2 entry |
Georgia Ragia, Vangelis G Manolopoulos |
| 376 |
[GO] |
Journal of Comparative Effectiveness Research |
2020―Nov―27 |
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019 |
Mohamed Rafiullah, Khalid Siddiqui |
| 377 |
[GO] |
Future Virology |
2020―Nov―26 |
The role of artificial intelligence in tackling COVID-19 |
Neelima Arora, Amit K Banerjee, Mangamoori L Narasu |
| 378 |
[GO] |
Epigenomics |
2020―Nov―26 |
An integrative analysis identifying transcriptional features and key genes involved in COVID-19 |
Guoping Li, Junyi Wang, Xiang He, Lei Zhang, Qin Ran, Anying Xiong, Dehong Wu, Lingjuan Hu, Qi Song, Dong Zhu |
| 379 |
[GO] |
Future Virology |
2020―Nov―26 |
Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh |
Nadim Sharif, Shuvra K Dey |
| 380 |
[GO] |
Future Microbiology |
2020―Nov―24 |
Chloroquine/hydroxycloroquine and COVID-19: need to know more about |
Antonio Cassone, Licia Iacoviello, Roberto Cauda |
| 381 |
[GO] |
Future Microbiology |
2020―Nov―20 |
The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic |
Lígia N de M Ribeiro, Belchiolina B Fonseca |
| 382 |
[GO] |
Future Microbiology |
2020―Nov―12 |
Effective optimization of SARS-CoV-2 laboratory testing variables in an era of supply chain constraints |
Nikhil S Sahajpal, Ashis K Mondal, Allan Njau, Sudha Ananth, Kimya Jones, Pankaj K Ahluwalia, Meenakshi Ahluwalia, Yasmeen Jilani, Alka Chaubey, Madhuri Hegde, Vamsi Kota, Amyn Rojiani, Ravindra Kolhe |
| 383 |
[GO] |
Neurodegenerative Disease Management |
2020―Nov―11 |
Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use? |
Andrew J Larner |
| 384 |
[GO] |
Future Microbiology |
2020―Nov―06 |
Clinical microbiology laboratories and COVID-19: the calm before the storm |
Joseph M Blondeau |
| 385 |
[GO] |
Future Microbiology |
2020―Nov―06 |
Risks of SARS-CoV-2 on male reproductive health and the practice of semen analysis and cryopreservation |
Michael B Yakass, Osbourne Quaye, Bryan J Woodward |
| 386 |
[GO] |
Future Virology |
2020―Nov―04 |
LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? |
Su M Metcalfe |
| 387 |
[GO] |
Future Microbiology |
2020―Nov―03 |
Coronavirus pandemic: treatment and future prevention |
Kenneth Lundstrom |
| 388 |
[GO] |
Future Cardiology |
2020―Oct―30 |
Cardiology and COVID-19: do we have sufficient information? |
Nikita Garg, Brendan McClafferty, Devyani Ramgobin, Reshma Golamari, Rahul Jain, Rohit Jain |
| 389 |
[GO] |
Future Virology |
2020―Oct―28 |
A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 |
Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, Jie Guo, Jin-Li Lou, Ya-Jie Wang |
| 390 |
[GO] |
Future Virology |
2020―Oct―27 |
Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection |
Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam |
| 391 |
[GO] |
Future Virology |
2020―Oct―22 |
Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA |
Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng |
| 392 |
[GO] |
Future Microbiology |
2020―Oct―21 |
Systemic mycoses: a potential alert for complications in COVID-19 patients |
Gonzalo Segrelles-Calvo, Glauber R de S Araújo, Susana Frases |
| 393 |
[GO] |
Future Microbiology |
2020―Oct―21 |
Mutation profile of over 4500 SARS-CoV-2 isolations reveals prevalent cytosine-to-uridine deamination on viral RNAs |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
| 394 |
[GO] |
Future Cardiology |
2020―Oct―20 |
Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19 |
Asad J Torabi, Josue Villegas-Galaviz, Maya Guglin, Kyle Frick, Roopa Rao |
| 395 |
[GO] |
Future Virology |
2020―Oct―14 |
A comprehensive review about SARS-CoV-2 |
SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed |
| 396 |
[GO] |
Future Virology |
2020―Oct―13 |
Implications of current and future approaches to coronavirus disease 2019 testing |
Rasheid Smith, Sean M Geary, Aliasger K Salem |
| 397 |
[GO] |
Future Cardiology |
2020―Oct―09 |
Abnormal left ventricular global longitudinal strain by speckle tracking echocardiography in COVID-19 patients |
Lori B Croft, Parasuram Krishnamoorthy, Richard Ro, Malcolm Anastasius, Wenli Zhao, Samantha Buckley, Martin Goldman, Edgar Argulian, Samin K Sharma, Annapoorna Kini, Stamatios Lerakis |
| 398 |
[GO] |
Future Virology |
2020―Oct―08 |
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 |
Jaclyn Kelly Mann, Thumbi Ndung'u |
| 399 |
[GO] |
Future Virology |
2020―Oct―08 |
In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 |
Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan |
| 400 |
[GO] |
Immunotherapy |
2020―Sep―22 |
COVID-19 and the newly rediscovered multidisciplinarity |
Melissa Bersanelli |
| 401 |
[GO] |
Future Microbiology |
2020―Sep―21 |
Potential alteration of COVID-19 by beta-mercaptoethanol |
Robert E Click |
| 402 |
[GO] |
Future Cardiology |
2020―Sep―18 |
Acute type A aortic dissection in a patient with COVID-19 |
Shiva Tabaghi, Mohammad Ali Akbarzadeh |
| 403 |
[GO] |
Pain Management |
2020―Sep―18 |
Reevaluating chronic opioid monitoring during and after the COVID-19 pandemic |
Prashant N Rao, Rohan Jotwani, Jatin Joshi, Amitabh Gulati, Neel Mehta |
| 404 |
[GO] |
Immunotherapy |
2020―Sep―16 |
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy |
Melissa Bersanelli, Teresa Zielli, Fabiana Perrone, Chiara Casartelli, Fabiana Pratticò, Elena Rapacchi, Roberta Camisa, Michele Tognetto, Alberto Clemente, Diana Giannarelli, Sara Elena Rebuzzi, Alessandro Leonetti, Paola Bordi, Marcello Tiseo, Sebastiano Buti |
| 405 |
[GO] |
Immunotherapy |
2020―Sep―09 |
COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy |
Cesar Martins da Costa, Zenaide Silva de Souza, Alessandra Corte Real Salgues, Guilherme Harada, Pedro Paulo Marino Rodrigues Ayres, Daniela Bulhões Vieira Nunes, Artur Katz, Rodrigo Ramella Munhoz |
| 406 |
[GO] |
Future Oncology |
2020―Sep―09 |
Bioethical considerations for cancer patients care during the COVID-19 pandemic |
Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad, Michel Scheuer, Roland Tomb |
| 407 |
[GO] |
Immunotherapy |
2020―Sep―09 |
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins |
José María Díez, Carolina Romero, Júlia Vergara-Alert, Melissa Belló-Perez, Jordi Rodon, José Manuel Honrubia, Joaquim Segalés, Isabel Sola, Luis Enjuanes, Rodrigo Gajardo |
| 408 |
[GO] |
Future Microbiology |
2020―Sep―03 |
SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall |
Cleo Anastassopoulou, Nicholas Spanakis, Athanasios Tsakris |
| 409 |
[GO] |
Nanomedicine |
2020―Sep―02 |
No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19 |
Georgia Wilson Jones, Marco P Monopoli, Luisa Campagnolo, Antonio Pietroiusti, Lang Tran, Bengt Fadeel |
| 410 |
[GO] |
Epigenomics |
2020―Sep―02 |
Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2 |
Antonella Baldassarre, Alessandro Paolini, Stefania Paola Bruno, Cristina Felli, Alberto Eugenio Tozzi, Andrea Masotti |
| 411 |
[GO] |
Future Oncology |
2020―Aug―28 |
Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for breast cancer survivors? |
Fatih Yildiz, Berna Oksuzoglu |
| 412 |
[GO] |
Future Microbiology |
2020―Aug―27 |
Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19) |
Elaheh Kordzadeh-Kermani, Hossein Khalili, Iman Karimzadeh |
| 413 |
[GO] |
Regenerative Medicine |
2020―Aug―26 |
Digital regenerative medicine and surgery pedagogy for virtual learning in the time of COVID-19 |
Saranya P Wyles, Fredric B Meyer, Richard Hayden, Isobel Scarisbrick, Andre Terzic |
| 414 |
[GO] |
Future Microbiology |
2020―Aug―26 |
Phages in the fight against COVID-19? |
Andrzej Górski, Ryszard Międzybrodzki, Maciej Żaczek, Jan Borysowski |
| 415 |
[GO] |
Future Virology |
2020―Aug―26 |
Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic |
Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan |
| 416 |
[GO] |
Future Virology |
2020―Aug―26 |
Genetic and pathogenic characterization of SARS-CoV-2: a review |
Afsane Bahrami, Gordon A Ferns |
| 417 |
[GO] |
Future Oncology |
2020―Aug―20 |
Breast cancer surgery after the COVID-19 pandemic |
Fiona Tsang-Wright, Marios-Konstantinos Tasoulis, Nicola Roche, Fiona MacNeill |
| 418 |
[GO] |
Future Virology |
2020―Aug―18 |
A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases |
Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra |
| 419 |
[GO] |
Future Virology |
2020―Aug―17 |
Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 |
Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid |
| 420 |
[GO] |
Future Microbiology |
2020―Aug―14 |
Anal swab as the potentially optimal specimen for SARS-CoV-2 detection to evaluate the hospital discharge of COVID-19 patients |
Mei Sun, Dong Guo, Jing Zhang, Jian Zhang, Hai-Feng Teng, Jun Xia, Peng Liu, Quan-Xu Ge, Ming-Yi Wang |
| 421 |
[GO] |
Future Virology |
2020―Aug―12 |
Thoughts on detecting tissue distribution of potential COVID-19 receptors |
Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi |
| 422 |
[GO] |
Pain Management |
2020―Aug―10 |
Impact of COVID-19 on chronic pain patients: a pain physician’s perspective |
Saba Javed, Joey Hung, Billy K Huh |
| 423 |
[GO] |
Future Oncology |
2020―Aug―10 |
Recapitulating intracavitary brachytherapy in cervical cancer patients during the COVID-19 pandemic: a viewpoint |
Divyesh Kumar, Treshita Dey |
| 424 |
[GO] |
Colorectal Cancer |
2020―Aug―07 |
Therapeutic challenges in colorectal surgery practice during COVID-19 outbreak: a case series |
Mahdi Alemrajabi, Mohammad Moradi, Esmail Amiri, Masoud Vahdani |
| 425 |
[GO] |
Future Cardiology |
2020―Aug―04 |
Biventricular strain by speckle tracking echocardiography in COVID-19: findings and possible prognostic implications |
Parasuram Krishnamoorthy, Lori B Croft, Richard Ro, Malcolm Anastasius, Wenli Zhao, Gennaro Giustino, Edgar Argulian, Martin E Goldman, Samin K Sharma, Annapoorna Kini, Stamatios Lerakis |
| 426 |
[GO] |
Melanoma Management |
2020―Jul―31 |
Pandemic medicine: the management of advanced melanoma during COVID-19 |
James R Patrinely, Douglas B Johnson |
| 427 |
[GO] |
Nanomedicine |
2020―Jul―29 |
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 |
Noura H Abd Ellah, Sheryhan F Gad, Khalid Muhammad, Gaber E Batiha, Helal F Hetta |
| 428 |
[GO] |
Future Virology |
2020―Jul―29 |
In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome |
Bader Y Alhatlani |
| 429 |
[GO] |
Future Virology |
2020―Jul―27 |
COVID-19: studying the global pandemic - foreword |
Stefano Rusconi, Frederick G Hayden |
| 430 |
[GO] |
Future Virology |
2020―Jul―27 |
Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future |
Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem |
| 431 |
[GO] |
Future Oncology |
2020―Jul―27 |
Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic |
Hagar Elghazawy, Joaira Bakkach, Mohamed S Zaghloul, Atlal Abusanad, Mariam Mohamed Hussein, Mohamed Alorabi, Nermean Bahie eldin, Thanaa Helal, Tarek M Zaghloul, Bhanu Prasad Venkatesulu, Hesham Elghazaly, Sana Al-Sukhun |
| 432 |
[GO] |
Biomarkers in Medicine |
2020―Jul―21 |
The role of hematological parameters in COVID-19 patients in the emergency room |
Eren Usul, İshak Şan, Burak Bekgöz, Ali Şahin |
| 433 |
[GO] |
Immunotherapy |
2020―Jul―17 |
Obesity, COVID-19 and immunotherapy: the complex relationship! |
Carmine Finelli |
| 434 |
[GO] |
Future Oncology |
2020―Jul―17 |
How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer |
Cengiz Karacin, Irem Bilgetekin, Fatma B Basal, Omur B Oksuzoglu |
| 435 |
[GO] |
Future Microbiology |
2020―Jul―17 |
COVID-19: in the absence of vaccination - ‘mask-the-nation’ |
Roy D Sleator, Steven Darby, Alan Giltinan, Niall Smith |
| 436 |
[GO] |
Biomarkers in Medicine |
2020―Jul―17 |
The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort |
Shant Ayanian, Juan Reyes, Lei Lynn, Karolyn Teufel |
| 437 |
[GO] |
Immunotherapy |
2020―Jul―15 |
Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients |
Juan David Cala-García, Juan David Sierra-Bretón, Jorge Eduardo Cavelier-Baiz, Álvaro A Faccini-Martínez, Carlos Eduardo Pérez-Díaz |
| 438 |
[GO] |
Future Microbiology |
2020―Jul―14 |
N-acetylcysteine as a potential treatment for novel coronavirus disease 2019 |
Rangel-Méndez Jorge-Aarón, Moo-Puc Rosa-Ester |
| 439 |
[GO] |
Future Oncology |
2020―Jul―13 |
The psychological challenges for oncological patients in times of COVID-19 pandemic: telemedicine, a solution? |
Estelle Caroline Schade, Ronaldo Elkaddoum, Hampig Raphael Kourie |
| 440 |
[GO] |
Future Oncology |
2020―Jul―13 |
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer |
Veronica Mollica, Alessandro Rizzo, Francesco Massari |
| 441 |
[GO] |
Future Cardiology |
2020―Jul―10 |
The impact of COVID-19 on critical cardiac care and what is to come postpandemic |
Justin Hall |
| 442 |
[GO] |
Immunotherapy |
2020―Jul―09 |
How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology |
Ting Yi Jessica Chang, Janet E Pope |
| 443 |
[GO] |
Future Microbiology |
2020―Jul―08 |
The use of radiological imaging alongside reverse transcriptase PCR in diagnosing novel coronavirus disease 2019: a narrative review |
Michael Naguib, Fathi Moustafa, Mustafa Thaer Salman, Nermin Kamal Saeed, Manaf Al-Qahtani |
| 444 |
[GO] |
Future Cardiology |
2020―Jul―03 |
Sudden cardiac death in COVID-19 patients, a report of three cases |
Samira Shirazi, Sanaz Mami, Negar Mohtadi, Abas Ghaysouri, Hamed Tavan, Ali Nazari, Taleb Kokhazadeh, Reza Mollazadeh |
| 445 |
[GO] |
Future Cardiology |
2020―Jul―01 |
Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure |
Bhurint Siripanthong, Thomas C Hanff, Michael G Levin, Mahesh K Vidula, Mohammed Y Khanji, Saman Nazarian, Choudhary Anwar A Chahal |
| 446 |
[GO] |
Immunotherapy |
2020―Jun―29 |
Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19 |
Lidia Gatto, Enrico Franceschi, Vincenzo Di Nunno, Alba Ariela Brandes |
| 447 |
[GO] |
Future Oncology |
2020―Jun―27 |
Implications of COVID-19 on urological laparoscopic surgery |
Benjamin Condon, Thomas Whish-Wilson, Niall F Davis, Nathan Lawrentschuk |
| 448 |
[GO] |
Future Virology |
2020―Jun―26 |
COVID-19 in homeless populations: unique challenges and opportunities |
Brian Conway, David Truong, Kelli Wuerth |
| 449 |
[GO] |
Future Oncology |
2020―Jun―25 |
Cancer management challenge in a developing country in COVID-19 pandemic: reflection of a group of Moroccan oncologists |
Hind Mrabti, Narjiss Berrada, Ghislaine Raiss, Hamza Ettahri, Halima Abahssain, Mouna Bourhafour, Souha Sahraoui, Hassan Errihani |
| 450 |
[GO] |
Future Oncology |
2020―Jun―22 |
A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? |
Emre Yekedüz, Ayşe Müge Karcıoğlu, Güngör Utkan, Yüksel Ürün |
| 451 |
[GO] |
Colorectal Cancer |
2020―Jun―20 |
Official French SARS-CoV-2 guidelines for cancer patients, a triage solution with precision medicine |
Juan Manuel O’Connor, Federico Esteso, Matías Chacón |
| 452 |
[GO] |
Immunotherapy |
2020―Jun―17 |
Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019 |
Megan Melody, Jared Nelson, Jacquelyn Hastings, Joshua Propst, Michael Smerina, Julio Mendez, Pramod Guru |
| 453 |
[GO] |
Future Virology |
2020―Jun―12 |
COVID-19 and coronaviral hepatitis: evidence of collateral damage |
Mohammad K Parvez |
| 454 |
[GO] |
Future Virology |
2020―Jun―12 |
Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection |
Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin |
| 455 |
[GO] |
Future Microbiology |
2020―Jun―11 |
Focus on a 2019-novel coronavirus (SARS-CoV-2) |
Ling-Pu Zhang, Meixian Wang, Yanping Wang, Jun Zhu, Nannan Zhang |
| 456 |
[GO] |
Pharmacogenomics |
2020―Jun―10 |
Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing? |
Elissar Moujaess, Hampig Raphael Kourie, Joseph Kattan |
| 457 |
[GO] |
Pharmacogenomics |
2020―Jun―05 |
Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations |
Eric M Snyder, Bruce D Johnson |
| 458 |
[GO] |
Epigenomics |
2020―Jun―04 |
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
Sameer Ayaz, Francesco Crea |
| 459 |
[GO] |
Biomarkers in Medicine |
2020―Jun―03 |
Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19 |
Juyi Li, Meng Li, Shasha Zheng, Menglan Li, Minghua Zhang, Minxian Sun, Xiang Li, Aiping Deng, Yi Cai, Hongmei Zhang |
| 460 |
[GO] |
Immunotherapy |
2020―Jun―03 |
Risk of SARS-CoV-2 infection and disease in metastatic triple-negative breast cancer patients treated with immune checkpoint inhibitors |
Patrizia Vici, Laura Pizzuti, Eriseld Krasniqi, Andrea Botticelli, Gennaro Ciliberto, Maddalena Barba |
| 461 |
[GO] |
Future Oncology |
2020―May―29 |
The future of cancer research after COVID-19 pandemic: recession? |
Hampig Raphael Kourie, Roland Eid, Fady Haddad, Marwan Ghosn, Dolla Karam Sarkis |
| 462 |
[GO] |
Future Virology |
2020―May―29 |
A suspected case of COVID-19 turned into a confirmed case: a case report from Iran |
Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, Xiaomin Liu, Zheng Yuan, Te Xiao, Wenshan Zhao, Xuefei Duan |
| 463 |
[GO] |
Future Oncology |
2020―May―29 |
Facing SARS-CoV-2 outbreak in immunotherapy era |
Fabrizio Citarella, Marco Russano, Francesco Pantano, Emanuela Dell'Aquila, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini |
| 464 |
[GO] |
Nanomedicine |
2020―May―28 |
Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? |
Vuk Uskoković |
| 465 |
[GO] |
Future Oncology |
2020―May―27 |
Hematopoietic stem cell transplantation dilemma during the COVID-19 era |
Ramy Samaha, Joseph Kattan |
| 466 |
[GO] |
Future Oncology |
2020―May―27 |
Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? |
Priya Hays |
| 467 |
[GO] |
Future Oncology |
2020―May―26 |
Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era |
Antonello Veccia, Stefania Kinspergher, Mariachiara Dipasquale, Orazio Caffo |
| 468 |
[GO] |
Future Virology |
2020―May―26 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise |
John Nemunaitis, Laura Stanbery, Neil Senzer |
| 469 |
[GO] |
Future Oncology |
2020―May―21 |
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy |
Alba A Brandes, Andrea Ardizzoni, Fabrizio Artioli, Federico Cappuzzo, Luigi Cavanna, Giovanni Luca Frassineti, Antonio Frassoldati, Francesco Leonardi, Giuseppe Longo, Antonio Maestri, Davide Tassinari, Enrico Franceschi, Vincenzo Di Nunno, Carmine Pinto |
| 470 |
[GO] |
Future Virology |
2020―May―20 |
Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections |
Mona Fani, Ali Teimoori, Shokouh Ghafari |
| 471 |
[GO] |
Biomarkers in Medicine |
2020―May―19 |
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis |
Nicola Ielapi, Noemi Licastro, Michele Provenzano, Michele Andreucci, Stefano de Franciscis, Raffaele Serra |
| 472 |
[GO] |
Future Oncology |
2020―May―15 |
The management of patients with metastatic prostate cancer during the COVID-19 pandemic |
Tarek Assi, Nathalie Ibrahim, Rita-Maria K Abboud, Clarisse Kattan, Elie Rassy, Elie Nemr, Joseph Kattan |
| 473 |
[GO] |
Future Oncology |
2020―May―14 |
Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19 |
Xuan Rui Sean Ong, Benjamin Condon, Dominic Bagguley, Nathan Lawrentschuk, Arun Azad, Declan Murphy |
| 474 |
[GO] |
Future Oncology |
2020―May―14 |
Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what’s old is new again? |
Ellen O'Connor, Jiasian Teh, Ashish M Kamat, Nathan Lawrentschuk |
| 475 |
[GO] |
Future Oncology |
2020―May―14 |
Oncology clinical trials in the time of COVID-19: how a pandemic can revolutionize patients’ care |
Francesco Massari, Veronica Mollica, Stefania Salvagni, Michele Tognetto, Andrea Ardizzoni |
| 476 |
[GO] |
Future Oncology |
2020―May―14 |
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) |
Elisa Maria Stroppa, Ilaria Toscani, Chiara Citterio, Elisa Anselmi, Elena Zaffignani, Mauro Codeluppi, Luigi Cavanna |
| 477 |
[GO] |
Immunotherapy |
2020―May―13 |
Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens |
José-María Díez, Carolina Romero, Rodrigo Gajardo |
| 478 |
[GO] |
Future Virology |
2020―May―12 |
Prediction and analysis of key protein structures of 2019-nCoV |
Qihao Li, Wen Peng, Yu Ou |
| 479 |
[GO] |
Journal of Comparative Effectiveness Research |
2020―May―11 |
Life after COVID-19: R WE going to help? |
Sreeram V Ramagopalan, Radek Wasiak |
| 480 |
[GO] |
Nanomedicine |
2020―May―07 |
Application of nanomaterials in treatment, anti-infection and detection of coronaviruses |
Ghazal Nikaeen, Sepideh Abbaszadeh, Saeed Yousefinejad |
| 481 |
[GO] |
Future Oncology |
2020―May―01 |
Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities |
Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid, Hampig Raphael Kourie |
| 482 |
[GO] |
Lung Cancer Management |
2020―May―01 |
Lung cancer management challenges amidst COVID-19 pandemic: hope lives here |
Abhishek Shankar, Deepak Saini, Ruchir Bhandari, Sachidanand Jee Bharati, Sunil Kumar, Geetika Yadav, Tarun Durga, Nalin Goyal |
| 483 |
[GO] |
Immunotherapy |
2020―Apr―30 |
COVID-19: the use of immunotherapy in metastatic lung cancer |
Alexander P Davis, Michael Boyer, Jenny H Lee, Steven C Kao |
| 484 |
[GO] |
Future Virology |
2020―Apr―24 |
The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
| 485 |
[GO] |
Future Oncology |
2020―Apr―23 |
What the oncologist needs to know about COVID-19 infection in cancer patients |
Elie Rassy, Rita-Maria Khoury-Abboud, Nathalie Ibrahim, Clarisse Kattan, Tarek Assi, Joseph Kattan |
| 486 |
[GO] |
Future Oncology |
2020―Apr―23 |
The impact of the coronavirus pandemic on the management of cancer patients in Lebanon: a single institutional experience |
Clarisse Kattan, Hassan Badreddine, Elie Rassy, Hampig Raphael Kourie, Joseph Kattan |
| 487 |
[GO] |
Future Cardiology |
2020―Apr―17 |
Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic |
Nili Schamroth Pravda, Miri Schamroth Pravda, Ran Kornowski, Katia Orvin |
| 488 |
[GO] |
Future Virology |
2020―Apr―17 |
Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
| 489 |
[GO] |
Colorectal Cancer |
2020―Apr―16 |
Colorectal cancer care in the age of coronavirus: strategies to reduce risk and maintain benefit |
John L Marshall, Ronit I Yarden, Benjamin A Weinberg |
| 490 |
[GO] |
Immunotherapy |
2020―Apr―15 |
Do checkpoint inhibitors compromise the cancer patients’ immunity and increase the vulnerability to COVID-19 infection? |
Joseph Kattan, Clarisse Kattan, Tarek Assi |
| 491 |
[GO] |
Future Oncology |
2020―Apr―08 |
The Lebanese Society of Medical Oncology (LSMO) statement on the care of patients with cancer during the COVID-19 pandemic |
Nizar Bitar, Joseph Kattan, Hampig Raphael Kourie, Deborah Mukherji, Nagi El Saghir |
| 492 |
[GO] |
Immunotherapy |
2020―Mar―26 |
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors |
Melissa Bersanelli |
